28.07.2013 Views

Research and capacity building Eastern Mediterranean Region

Research and capacity building Eastern Mediterranean Region

Research and capacity building Eastern Mediterranean Region

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

WHO-EM/PHP/036/E<br />

<strong>Research</strong> <strong>and</strong> <strong>capacity</strong> <strong>building</strong><br />

in trade in health services in the<br />

<strong>Eastern</strong> <strong>Mediterranean</strong> <strong>Region</strong><br />

Rabat, Morocco, 30 May– 1 June 2006


© World Health Organization 2006<br />

All rights reserved.<br />

The designations employed <strong>and</strong> the presentation of the material in this publication<br />

do not imply the expression of any opinion whatsoever on the part of the World<br />

Health Organization concerning the legal status of any country, territory, city or area<br />

or of its authorities, or concerning the delimitation of its frontiers or boundaries.<br />

Dotted lines on maps represent approximate border lines for which there may not yet<br />

be full agreement.<br />

The mention of specific companies or of certain manufacturers’ products does not<br />

imply that they are endorsed or recommended by the World Health Organization in<br />

preference to others of a similar nature that are not mentioned. Errors <strong>and</strong> omissions<br />

excepted, the names of proprietary products are distinguished by initial capital<br />

letters.<br />

The World Health Organization does not warrant that the information contained in<br />

this publication is complete <strong>and</strong> correct <strong>and</strong> shall not be liable for any damages<br />

incurred as a result of its use.<br />

Publications of the World Health Organization can be obtained from Distribution<br />

<strong>and</strong> Sales, World Health Organization, <strong>Region</strong>al Office for the <strong>Eastern</strong><br />

<strong>Mediterranean</strong>, PO Box 7608, Nasr City, Cairo 11371, Egypt (tel: +202 670 2535, fax:<br />

+202 670 2492; email: DSA@emro.who.int). Requests for permission to reproduce<br />

WHO EMRO publications, in part or in whole, or to translate them – whether for sale<br />

or for noncommercial distribution – should be addressed to the <strong>Region</strong>al Adviser,<br />

Health <strong>and</strong> Biomedical Information, at the above address (fax: +202 276 5400; email<br />

HBI@emro.who.int).<br />

Printed by El Balagh, Cairo<br />

Document WHO-EM/PHP/036/E/12.06/300


Contents<br />

1. Introduction .......................................................................................5<br />

2. Globalization, trade <strong>and</strong> health.....................................................11<br />

2.1 Globalization, trade <strong>and</strong> health: WHO perspective.........11<br />

2.2 Underst<strong>and</strong>ing commitments in health services<br />

under GATS ...........................................................................14<br />

2.3 GATS application to health services...................................17<br />

2.4 Trade <strong>and</strong> health: a tool kit for analysis <strong>and</strong><br />

assessment<br />

of countries............................................................................18<br />

2.5 Discussion on presentations ................................................19<br />

3. <strong>Region</strong>al experience in trade in health services ..........................22<br />

3.1 Methodological framework for assessing trade<br />

in health services ..................................................................22<br />

3.2 Challenge of assessing trade in health services:<br />

experience from the <strong>Eastern</strong> <strong>Mediterranean</strong> <strong>Region</strong>.......25<br />

3.3 Egypt.......................................................................................30<br />

3.4 Jordan......................................................................................32<br />

3.5 Lebanon ..................................................................................35<br />

3.6 Morocco ..................................................................................36<br />

3.7 Oman ......................................................................................38<br />

3.8 Pakistan ..................................................................................39<br />

3.9 Sudan .....................................................................................40<br />

3.1 0 Syrian Arab Republic............................................................42<br />

3.11 Tunisia ....................................................................................44<br />

3.12 Yemen .....................................................................................45<br />

3.13 Discussion on the country studies......................................46<br />

4. Working groups...............................................................................48<br />

5. Recommendations...........................................................................52<br />

Annexes<br />

1. Programme .............................................................................................54<br />

2. List of participants.................................................................................56


1. Introduction<br />

Globalization represents a challenge to health systems, both in<br />

the <strong>Eastern</strong> <strong>Mediterranean</strong> <strong>Region</strong> (EMR) of the World Health<br />

Organization (WHO) <strong>and</strong> worldwide. The opening up of trade in<br />

health services will create new opportunities for health systems while<br />

also putting pressure on them <strong>and</strong> creating new challenges for them.<br />

Health systems are expected to benefit in particular from<br />

developments in information technology, which will facilitate access<br />

to up-to-date biomedical technology <strong>and</strong> skills for large segments of<br />

the population. At the same time, concerns have been expressed<br />

about the potential negative impacts of free trade in health services<br />

on access to essential health services, on the existing “brain drain” of<br />

qualified professionals from the <strong>Region</strong> <strong>and</strong> on overall equity with<br />

respect to health care.<br />

Over the past two years the WHO <strong>Region</strong>al Office for the<br />

<strong>Eastern</strong> <strong>Mediterranean</strong> (EMRO), International Development <strong>Research</strong><br />

Centre (IDRC) of Canada <strong>and</strong> United Nations Population Fund<br />

(UNFPA) Egypt, have undertaken a joint Concerted Action for<br />

<strong>Research</strong> <strong>and</strong> Capacity Building in Trade in Health Services in the<br />

<strong>Eastern</strong> <strong>Mediterranean</strong> <strong>Region</strong> to comprehend the influence of trade<br />

on the efficient <strong>and</strong> equitable provision of health services. While<br />

international trade in health services has grown globally in recent<br />

years, the General Agreement on Trade in Services (GATS) has been<br />

instrumental in stimulating current thinking on the implications of<br />

globalization <strong>and</strong> the opening up of trade in health services for<br />

creating new opportunities <strong>and</strong> challenges for health systems.<br />

The <strong>Region</strong>al Office has been intensively involved in assessing<br />

the status of trade in health services in 10 countries of the <strong>Region</strong>:<br />

Egypt, Jordan, Lebanon, Morocco, Oman, Pakistan, Sudan, Syrian<br />

Arab Republic, Tunisia <strong>and</strong> Yemen. The results of these studies were<br />

shared with national policy-makers during the <strong>Region</strong>al Consultative<br />

Meeting on <strong>Research</strong> <strong>and</strong> Capacity Building in Trade in Health<br />

Services in the <strong>Eastern</strong> <strong>Mediterranean</strong> <strong>Region</strong>, held in Rabat,<br />

Morocco, from May 30 to June 1 2006 (for the programme see Annex


6 Trade in health services in the <strong>Eastern</strong> <strong>Mediterranean</strong> <strong>Region</strong><br />

1). The participants included country researchers, national health <strong>and</strong><br />

trade policy-makers, multilateral trade <strong>and</strong> health agencies,<br />

international development agencies, members of academia <strong>and</strong> civil<br />

society, <strong>and</strong> WHO staff (for the participants list see Annex 2).<br />

The Minister of Health of Morocco, His Excellency, Dr<br />

Mohamed Cheikh Biadillah, welcomed participants. He observed that<br />

it was a time of frontiers falling in the face of market-driven financial<br />

<strong>and</strong> trade flows, <strong>and</strong> the establishment of intellectual property laws.<br />

These events gave rise to various important questions of public<br />

concern: was it possible to protect ourselves in some areas of activity,<br />

were health services also going to be liberalized <strong>and</strong> what would<br />

become of hospitals, pharmacies <strong>and</strong> clinics?<br />

Trade liberalization had many effects on health, he noted. The<br />

lowering of custom tariffs improved access to medical technology<br />

<strong>and</strong> made medication available at reduced prices. However,<br />

modification of international regulations governing patents affected<br />

access to essential medicines, <strong>and</strong> national health regulations <strong>and</strong><br />

st<strong>and</strong>ards impacted on multilateral trade.<br />

He pointed out that GATS would have implications for the<br />

health sector on at least four levels: transnational supply of services<br />

(e.g. telemedicine); consumption of services abroad (treatment in<br />

another country); commercial presence (creation of health services in<br />

another country); <strong>and</strong> the brain drain of human resources.<br />

The involvement of countries in the management of these areas<br />

<strong>and</strong> in measures adopted in response would be beneficial, he said.<br />

Ministries of health should develop their <strong>capacity</strong> for analysis <strong>and</strong><br />

their knowledge of trade issues <strong>and</strong> their relation to health services.<br />

Collaboration should be strengthened with ministries of commerce<br />

<strong>and</strong> finance in order to anticipate <strong>and</strong> predict the impact of WTO<br />

measures.<br />

He congratulated WHO for according priority to the subject<br />

<strong>and</strong> for having established mechanisms of consultation with the Food<br />

<strong>and</strong> Agriculture Organization of the United Nations (FAO), United<br />

Nations Conference on Trade <strong>and</strong> Development (UNCTAD), World<br />

Intellectual Property Organization (WIPO), World Trade


Organization (WTO), etc. Since the Fifty-sixth World Health<br />

Assembly in 2003, WHO had been following developments <strong>and</strong> the<br />

implementation of the Doha Agreement, especially where they<br />

concerned public health <strong>and</strong> trade-related aspects of intellectual<br />

property rights (TRIPS).<br />

He pointed out that the meeting came at the right time to help<br />

health services decision-makers, managers <strong>and</strong> providers to find<br />

answers to their many questions in this field. He concluded by saying<br />

that he looked forward to the thoughts <strong>and</strong> comments of participants<br />

on the subject, <strong>and</strong> wished them full success in their work.<br />

UNFPA Representative in Egypt, Dr Faysal Abdel Gadir,<br />

speaking on the occasion, remarked that UNPFA Egypt was pleased<br />

to be part of this collaborative effort <strong>and</strong> was particularly interested<br />

in seeing progress in this field in Egypt. It was for this reason that<br />

UNFPA had supported a strong team that included Dr Mohammed<br />

Tag El Din, the former Minister of Health <strong>and</strong> Population of Egypt.<br />

Dr Abdel Gadir stated that UNFPA’s m<strong>and</strong>ate was in the area<br />

of reproductive health <strong>and</strong> it was interested to see how the<br />

liberalization of international trade in health services would impact<br />

on reproductive health services in Egypt. In addition, UNFPA Egypt<br />

was interested in looking into the broader area of international trade<br />

<strong>and</strong> health <strong>and</strong> in being able to assess how other trade agreements<br />

could influence reproductive health policies, such as on access to<br />

contraception, in the country. Finally, Dr Abdel Gadir thanked the<br />

WHO <strong>Region</strong>al Office for inviting UNFPA Egypt <strong>and</strong> wished the<br />

meeting complete success.<br />

Dr Raouf Ben Ammar, WHO Representative, Morocco,<br />

delivered a message by Dr Hussein A. Gezairy, WHO <strong>Region</strong>al<br />

Director for the <strong>Eastern</strong> <strong>Mediterranean</strong>.<br />

The objective of the workshop was to share the main policy<br />

findings of 10 country case studies on liberalizing trade in health<br />

services in the <strong>Eastern</strong> <strong>Mediterranean</strong> <strong>Region</strong> within the framework<br />

of GATS, he said. This research-to-policy workshop was the<br />

concluding activity of the Concerted Action for <strong>Research</strong> <strong>and</strong><br />

Capacity Building in the <strong>Eastern</strong> <strong>Mediterranean</strong> <strong>Region</strong>, initiated as a


8 Trade in health services in the <strong>Eastern</strong> <strong>Mediterranean</strong> <strong>Region</strong><br />

pioneer regional initiative in February 2004 in partnership with IDRC<br />

<strong>and</strong> UNFPA.<br />

GATS was one of the key agreements of the WTO <strong>and</strong> had<br />

brought trade in services for the first time within a multilateral<br />

framework. The Agreement aimed to gradually liberalize trade in<br />

services, including health services, carrying significant implications<br />

for the health care sectors of WTO member countries. To date, 10<br />

Member States of the <strong>Region</strong> were also members of the WTO, with an<br />

additional 6 countries maintaining observer status. While the process<br />

of services trade liberalization had been underway since 1995, much<br />

was yet to come on the health services front, he noted. Liberalization<br />

measures in this sector had been “back-loaded” or postponed, with<br />

the “wait-<strong>and</strong>-see” negotiations strategy reflecting concern over the<br />

potential impact of liberalization within the multilateral framework<br />

on the health care sector.<br />

Most countries had taken a conservative approach to the<br />

liberalization of trade in health services <strong>and</strong> the opening up of the<br />

health sector to the forces of globalization. One of the reasons behind<br />

this conservative approach was that the precise impact of<br />

globalization on the health services sector, in terms of efficiency,<br />

access <strong>and</strong> equity was difficult to evaluate. The need for a rigorous<br />

methodology to capture the impact of this phenomenon was,<br />

therefore, pertinent.<br />

One of the core components of the Concreted Action Plan was<br />

to develop a research methodology, which had been applied over the<br />

last two years in 10 countries of the <strong>Region</strong>. The policy messages of<br />

these studies should be instrumental in advising negotiators <strong>and</strong><br />

policy-makers on where to go next, <strong>and</strong> on how fast to advance on<br />

the liberalization front. Of no less importance, these country case<br />

studies had been able to provide key guidelines regarding the nature<br />

of the regulatory measures that should accompany the liberalization<br />

process, if it proceeded further.<br />

Trade in health services was not a new phenomenon, he noted.<br />

Traditional modes of trade whereby patients, physicians <strong>and</strong> students<br />

of medical sciences had been moving between countries in pursuit of


etter services, more prosperous livelihoods or education of higher<br />

quality had long been recorded <strong>and</strong> documented. More novel modes<br />

of trade such as cross-border supply of health services <strong>and</strong> foreign<br />

commercial presence were relatively new phenomena. Cross-border<br />

supply of health services had advanced in parallel with advances in<br />

communication <strong>and</strong> information technologies, <strong>and</strong> had become<br />

highly prolific, cutting down substantially on the cost of some<br />

medical services. Foreign direct investment (FDI) in the domain of<br />

health services was also on the rise, mainly due to the opening up of<br />

opportunities for the private sector to become an active player in the<br />

provision of health care services, especially in countries where this<br />

sector had traditionally been government dominated.<br />

There was an increased level of interest in assessing the impact<br />

of trade in health services, particularly in relation to public health<br />

considerations. Moreover, the question regarding the merits of<br />

liberalization within a multilateral framework versus unilateral<br />

liberalization, governed by national legislation, had been posed in<br />

most of the studies undertaken. The answers to these two questions<br />

would be debated over the coming few days, <strong>and</strong> it was hoped that<br />

by the end of the workshop clear policy messages would be available<br />

to policy-makers.<br />

He added that the liberalization of trade in services did not <strong>and</strong><br />

should not mean the absence of government regulatory control.<br />

Trade liberalization had its merits, as demonstrated by the case<br />

studies, yet in the absence of regulatory measures that ensured<br />

equality in the provision of health services as well as accessibility in<br />

the aftermath of liberalization, gains from trade may not accrue<br />

equally to all. It was the responsibility of policy-makers to ensure that<br />

gains from trade did not create a duality of health care systems or<br />

create shortages (“brain drain”) that would jeopardize the provision<br />

of essential health services.<br />

He concluded by describing some of the impediments that had<br />

been faced by researchers during their investigations. Data on trade<br />

in health services in the <strong>Region</strong> was sparse. The fragmented nature of<br />

data on trade in health services had been a key constraint on the


10 Trade in health services in the <strong>Eastern</strong> <strong>Mediterranean</strong> <strong>Region</strong><br />

evaluation of the impact of liberalization. Further, communication<br />

between health <strong>and</strong> trade officials over issues regarding trade <strong>and</strong><br />

health had not been systematic. Reaching coherency between policies<br />

adopted at both levels was instrumental to a successful negotiations<br />

process, he said. These two issues needed to be addressed by policymakers<br />

so that the liberalization process did not fall short of ensuring<br />

equitable access to health care services, the quality of health care <strong>and</strong><br />

the efficient use of resources.<br />

Dr Belgacem Sabri, Director, Division of Health Systems <strong>and</strong><br />

Services Development, stated that globalization represented a<br />

challenge to health systems, both in the <strong>Region</strong> <strong>and</strong> worldwide. The<br />

opening up of trade in health services provided new opportunities<br />

for health systems while creating new challenges. The <strong>Region</strong>al<br />

Office, IDRC <strong>and</strong> UNFPA Egypt had been engaged in the Concerted<br />

Action for <strong>Research</strong> <strong>and</strong> Capacity Building in Trade in Health<br />

Services in the <strong>Eastern</strong> <strong>Mediterranean</strong> <strong>Region</strong> since 2004. The purpose<br />

of this joint initiative was to:<br />

• build <strong>capacity</strong> of researchers <strong>and</strong> institutions in countries of the<br />

<strong>Eastern</strong> <strong>Mediterranean</strong> <strong>Region</strong> for undertaking research on<br />

trade in health services;<br />

• advance <strong>and</strong> refine the research methodology for assessing the<br />

impact of trade in health services for countries of the <strong>Region</strong><br />

<strong>and</strong> beyond;<br />

• undertake case studies in countries of the <strong>Region</strong> to document<br />

trade in health services;<br />

• disseminate the research results among concerned policymakers<br />

<strong>and</strong> stakeholders to create awareness <strong>and</strong> elicit<br />

appropriate responses from countries.<br />

Dr Sabri then updated the participants on the main activities of<br />

the project so far, including recruitment of a study coordinator,<br />

refinement of the research methodology <strong>and</strong> survey instruments,<br />

holding of a research methodology workshop on trade in health<br />

services <strong>and</strong> the carrying out of 10 country case studies.


Dr Sabri outlined the objectives of the meeting as follows:<br />

• to create increased awareness among national health <strong>and</strong> trade<br />

policy-makers of the public health implications of trade in<br />

health services;<br />

• to share <strong>and</strong> debate the findings of the country studies<br />

undertaken on the subject with relevant policy-makers <strong>and</strong><br />

stakeholders;<br />

• to review the methodological aspects of undertaking country<br />

studies in trade in health services;<br />

• to develop a shared underst<strong>and</strong>ing <strong>and</strong> a regional strategy <strong>and</strong><br />

planned response for liberalization of trade in health services.<br />

The Chairmen of the meeting were Dr Mohammed Tag El Din<br />

(Day 1) <strong>and</strong> Dr Walid Ammar (Day 2 <strong>and</strong> 3). The Rapporteurs were<br />

Kevin Eisenstadt, Azza El Shinnawy <strong>and</strong> Ahmed Mokhtar.<br />

2. Globalization, trade <strong>and</strong> health<br />

2.1 Globalization, trade <strong>and</strong> health: WHO perspective<br />

Dr Nick Drager<br />

GATS is one of the most important trade agreements to emerge<br />

from the Uruguay Round negotiations that created the WTO. Services<br />

are one of the fastest growing areas for many economies <strong>and</strong> services<br />

of many kinds play important roles in the protection <strong>and</strong> promotion<br />

of health. GATS, therefore, creates numerous challenges for people<br />

working in public health, particularly since it is a complex legal<br />

agreement that borrows from existing international trade law to<br />

create new rules for services. The Agreement has become the subject<br />

of significant controversy, especially with respect to how it will affect<br />

health-related services <strong>and</strong> health policy.<br />

The debate about the impact of GATS on health policy has<br />

created a “tale of two treaties”. From one perspective, GATS is<br />

regarded as one of the worst of treaties since it is seen to undermine<br />

the exercise of national sovereignty. From another perspective, GATS<br />

is the best of treaties, since it respects health sovereignty through its<br />

flexibility, which allows each WTO member to shape its obligations


12 Trade in health services in the <strong>Eastern</strong> <strong>Mediterranean</strong> <strong>Region</strong><br />

according to its national needs <strong>and</strong> interests. This “tale of two<br />

treaties” problem has made it difficult for the health policy<br />

communities to underst<strong>and</strong> how GATS may or may not affect their<br />

work. Risks <strong>and</strong> opportunities associated with trade in health services<br />

under the four GATS modes of supply are outlined in Table 1.<br />

Table 1. Health opportunities <strong>and</strong> risks<br />

Mode Opportunity Risk<br />

Mode I<br />

Increased care to remote Diversion of resources from<br />

Cross border<br />

supply of<br />

services<br />

<strong>and</strong> underserved areas other health services<br />

Mode 2<br />

Consumption<br />

abroad<br />

Mode 3<br />

Commercial<br />

presence<br />

Mode 4<br />

Presence of<br />

natural persons<br />

Generates foreign<br />

exchange earnings for<br />

health services<br />

Creates opportunities for<br />

new employment <strong>and</strong><br />

access to new<br />

technologies<br />

Economic gains from<br />

remittances of health care<br />

personnel working<br />

overseas<br />

Crowding out of local population<br />

<strong>and</strong> diversion of resources to<br />

service foreign nationals<br />

Development of two-tiered<br />

health system with an internal<br />

brain drain<br />

Permanent outflows of health<br />

personnel, with loss of<br />

investment in educating <strong>and</strong><br />

training such personnel<br />

It is important to assess the impact of liberalized trade in health<br />

services on access to, cost <strong>and</strong> quality of health services. Policies <strong>and</strong><br />

regulations should be in place to ensure that trade in health services<br />

increases equity in health <strong>and</strong> is in the interest of those in greatest<br />

need.<br />

The need for progressive liberalization within the GATS<br />

framework means that WHO members face decisions about whether<br />

or not to liberalize trade in services through market access <strong>and</strong><br />

national treatment commitments, including trade in health-related<br />

services. In relation to this, the GATS round of liberalization<br />

negotiations will potentially affect health policy in two areas:<br />

evaluating requests from other countries for, <strong>and</strong> offers to other<br />

countries of, specific commitments for market access <strong>and</strong> national<br />

treatment; <strong>and</strong> negotiations on GATS rules.


From the point of view of WHO, managing the GATS process<br />

from a health policy perspective should ensure that:<br />

• liberalized trade in health-related services leads to an optimal<br />

balance between preventive <strong>and</strong> curative services;<br />

• there is involvement of both private industry <strong>and</strong> civil society to<br />

ensure that liberalization of health-related services promotes<br />

participatory health policy;<br />

• improving access <strong>and</strong> affordability of health-related services is<br />

a goal of liberalization of trade in health-related services;<br />

• developing countries, <strong>and</strong> least-developed countries in<br />

particular, receive special consideration in the process of<br />

liberalizing trade in health-related services;<br />

• the status of health as a human right informs <strong>and</strong> guides<br />

proposals to liberalize trade in health-related services.<br />

The following set of key questions also needs to be addressed:<br />

• To what extent is the sector already open to foreign service<br />

providers, <strong>and</strong> what have been the regulatory concerns posed<br />

by existing foreign competition?<br />

• Do the commitments fit the strategies <strong>and</strong> directions identified<br />

by national health policy?<br />

• What effects will the commitments have on governmentprovided<br />

health services?<br />

• What regulatory burdens will the commitments create for the<br />

government in health-related sectors?<br />

• Will the commitments eliminate or weaken regulatory<br />

approaches necessary for the protection <strong>and</strong> promotion of<br />

health?<br />

• What evidence <strong>and</strong> principles can be used to analyse the<br />

possible effect of the commitments?<br />

• Can the commitments be crafted to both protect health policy<br />

<strong>and</strong> liberalize trade progressively?<br />

Managing the GATS process from a health policy perspective<br />

requires that health principles <strong>and</strong> criteria should drive policy<br />

decisions on trade in health-related services in the GATS<br />

negotiations. It is worth remembering “who owns the house”: GATS


14 Trade in health services in the <strong>Eastern</strong> <strong>Mediterranean</strong> <strong>Region</strong><br />

provides countries with choices <strong>and</strong> does not force them to make<br />

liberalization commitments that are not in their best interests. If a<br />

country is unsure about the effects of making specific commitments,<br />

it is fully within its rights to decline to make legally binding<br />

commitments to liberalize, or to liberalize unilaterally without<br />

making binding commitments.<br />

2.2 Underst<strong>and</strong>ing commitments in health services under GATS<br />

Dr Sameen Siddiqi<br />

The purpose of GATS is to: create a credible <strong>and</strong> reliable system<br />

of international trade rules; ensure fair <strong>and</strong> equitable treatment of all<br />

participants; stimulate economic activity through guaranteed policy<br />

bindings; <strong>and</strong> promote trade <strong>and</strong> development through progressive<br />

liberalization. Liberalization of trade in health services has important<br />

public health implications, with both risks <strong>and</strong> benefits. Trade<br />

agreements can be multilateral such as GATS, regional (e.g. an Arab<br />

free trade agreement), or bilateral between two countries.<br />

There are certain threshold issues relating to GATS <strong>and</strong><br />

national health systems that need to be considered. These include: the<br />

extent of public or private financing in provision of health services;<br />

the extent to which the health system makes a distinction between<br />

national <strong>and</strong> foreign suppliers; the distinction between trade within<br />

<strong>and</strong> outside trade agreements; <strong>and</strong> the need for strong regulation in<br />

the face of liberalization of trade in health services. Most importantly,<br />

<strong>and</strong> despite some controversy, Article 1.3 of GATS ‘excludes services<br />

in the exercise of government authority’ as they are non-commercial<br />

<strong>and</strong> non-competitive.<br />

It is important to underst<strong>and</strong> how the health sector is defined<br />

under GATS . Member States can use their definitions, follow the UN<br />

Provisional Central Product Classification (UN CPC), or use WTO<br />

Services Sectoral Classification List (W 120), which has 12 Classes of<br />

Service Sectors. Box 1 shows how the health sector is defined under<br />

W 120. Members can define the scope of the sector <strong>and</strong> need not<br />

commit the entire sector.


Box 1. How the Health Sector is defined under GATS<br />

Class 8: Health Related <strong>and</strong> Social Services<br />

Hospital Services<br />

Other Human Health Services<br />

Social Services <strong>and</strong> Others<br />

Class 1: Business Services<br />

Professional Services<br />

(h) Medical <strong>and</strong> dental services<br />

(j) Services provided by midwives, nurses <strong>and</strong> paramedics<br />

Class 7: Financial Services<br />

All Insurance <strong>and</strong> Insurance Related Services<br />

Life, Accident <strong>and</strong> Health Insurance Services<br />

The four modes of supply under GATS are: cross-border supply<br />

(when only services cross the border); consumption abroad (when a<br />

consumer crosses the border to receive a service in another country);<br />

commercial presence (when there is FDI in a country to set up a<br />

facility to provide a service); <strong>and</strong> the movement of natural persons<br />

(when a provider moves to another country to provide a service).<br />

All WTO members have certain General Obligations, the most<br />

important of which is the Most Favoured Nation (MFN) status, which<br />

means treating all WTO members as you would treat your most<br />

favoured nation. Some exceptions to the MFN status are regional<br />

trade agreements, sectoral exemptions <strong>and</strong> recognition of<br />

qualifications, which has implications for the health sector.<br />

Additional obligations include transparency, review procedures for<br />

administrative decisions <strong>and</strong> certain basic competition disciplines.<br />

In addition, WTO members make certain modal commitments<br />

under GATS. When these cover a single mode of supply across all<br />

service sectors listed in the schedule, it is called a horizontal<br />

commitment. Sector-specific commitments for each mode can be<br />

made either as “market access” or “national treatment”. A<br />

commitment is a guaranteed minimum treatment to foreign service<br />

suppliers. A commitment under GATS means specifying the extent of


16 Trade in health services in the <strong>Eastern</strong> <strong>Mediterranean</strong> <strong>Region</strong><br />

market access <strong>and</strong> national treatment for each service sector <strong>and</strong><br />

mode of supply. GATS commitments are binding once locked into.<br />

Countries have choices when making commitments with<br />

regards to the extent of commitment:<br />

• None or full: provides full market access <strong>and</strong>/or national<br />

treatment for a particular mode (no restrictions)<br />

• Partial commitment: provides market access <strong>and</strong>/or national<br />

treatment, with restrictions<br />

• Unbound: provides no commitment at all on market access<br />

<strong>and</strong>/or national treatment for a particular mode.<br />

Countries also have flexibility on the level of liberalization<br />

under GATS, which could be kept at the current level of access, or set<br />

at a more liberal or more restricted level.<br />

Developing countries are not obliged to liberalize trade in<br />

health services <strong>and</strong> have the flexibility to open fewer sectors,<br />

liberalize fewer transactions, progressively increase market access<br />

<strong>and</strong> attach conditions in line with national policy objectives. GATS<br />

recognizes the right to regulate, but certain disciplines apply<br />

depending on whether the measure is non-discriminatory (foreign<br />

suppliers <strong>and</strong> nationals) or discriminatory (foreign suppliers only). If<br />

commitments are made for any mode, discriminatory measures need<br />

to be listed in the national treatment schedule.<br />

GATS allows members to recognize the qualifications of some<br />

members <strong>and</strong> not others (which breaks the MFN rule), but members<br />

mutually recognizing qualifications need to inform WTO <strong>and</strong> give<br />

others the opportunity to demonstrate that they also meet the<br />

required st<strong>and</strong>ards. Under GATS, members are free to set their own<br />

st<strong>and</strong>ards.<br />

Before making any commitment in the health sector, WTO<br />

members should thus consider whether GATS can help achieve any<br />

of the health policy outcomes being sought, how to regulate trade in<br />

health services to achieve the best health outcomes once commitment<br />

is made, <strong>and</strong> the level of national <strong>capacity</strong> required to regulate trade<br />

in health services <strong>and</strong> the measures necessary to improve it.


It is essential to have policy coherence between ministries of<br />

health <strong>and</strong> trade <strong>and</strong> other stakeholders before committing. For this<br />

to happen, a mechanism for policy coordination needs to be evolved.<br />

In addition, a solid evidence base is critical in order to underst<strong>and</strong> the<br />

public health implications of GATS <strong>and</strong> to ensure that these are not<br />

compromised.<br />

2.3 GATS application to health services<br />

Dr Rudolf Adlung<br />

Liberalization (of market access <strong>and</strong> national treatment) with<br />

respect to GATS should not be taken to be synonymous with<br />

deregulation. GATS recognizes the right of WTO member countries<br />

to regulate <strong>and</strong> to introduce new regulations to meet national policy<br />

objectives, particularly in the health care sector. Liberalization<br />

through reciprocal exchange of concessions within the GATS<br />

framework is deeper <strong>and</strong> gains an important element of credibility<br />

through binding commitments.<br />

While GATS is far wider in coverage then conventional trade<br />

agreements, it is extremely flexible in application. Countries have<br />

three possible scenarios. They can opt for having specific sectors not<br />

covered, such as in the case of governmental services <strong>and</strong> air traffic<br />

control. These sectors are excluded from coverage on the basis that<br />

they are ‘services provided in the exercise of governmental authority’<br />

which, in turn, are defined as services that are supplied ‘neither on a<br />

commercial basis, nor in competition with one or more service<br />

suppliers’ (Article 1:3). They can also opt for specific sectors being<br />

covered with no access obligations. In this case, minimum<br />

(“unconditional”) obligations include MFN treatment, transparency<br />

requirements <strong>and</strong> some other “good governance” provisions<br />

(availability of legal remedies, etc.), but there is no obligation to open<br />

markets. Governments can also opt for access obligations (“specific<br />

commitments”), which denotes three basic concepts: “market access”<br />

(absence of quota type <strong>and</strong> similar restrictions), “national treatment”<br />

(non-discrimination with regard to all measures affecting the supply<br />

of a service) <strong>and</strong> “additional commitments” (plus “unconditional”


18 Trade in health services in the <strong>Eastern</strong> <strong>Mediterranean</strong> <strong>Region</strong><br />

<strong>and</strong> '”conditional” obligations). Any limitations must be inscribed in<br />

the Schedules under the relevant modes. Scheduling a sector does not<br />

imply that trade must be liberalized across all modes. Specific<br />

commitments may vary across a spectrum between “unbound” (no<br />

commitment) <strong>and</strong> “none” (no limitation/full commitment). Specific<br />

commitments can be in a selection of sectors in which limitations are<br />

inscribed as less than status quo, the status quo or more liberal than<br />

the status quo.<br />

Of the 10 country studies: Lebanon, Sudan, Syrian Arab<br />

Republic <strong>and</strong> Yemen are not WTO members; Egypt, Morocco <strong>and</strong><br />

Tunisia are members without commitments on Medical <strong>and</strong> Hospital<br />

Services; <strong>and</strong> Jordan, Oman <strong>and</strong> Pakistan are members with<br />

commitments, Jordan <strong>and</strong> Oman in Medical <strong>and</strong> Hospital Services,<br />

<strong>and</strong> Pakistan in Hospital Services.<br />

The time-frame regarding trade in services negotiations is as<br />

follows: initial offers were submitted on 31 March 2003; revised offers<br />

on May 2005; <strong>and</strong> plurilateral requests on 28 February 2006. The<br />

second round of revised offers is to be submitted by 31 July 2006 <strong>and</strong><br />

the final draft schedules by 31 October 2006.<br />

2.4 Trade <strong>and</strong> health: a tool kit for analysis <strong>and</strong> assessment of<br />

countries<br />

Dr Nick Drager<br />

For a country analysis of the trade <strong>and</strong> health situation it is<br />

important to identify: the priority trade <strong>and</strong> health issues, including<br />

the policy <strong>and</strong> regulatory framework; any trade in health goods <strong>and</strong><br />

health-related services; any trade agreements <strong>and</strong> ongoing<br />

negotiations; the institutional <strong>capacity</strong> to manage trade liberation;<br />

<strong>and</strong> the elements of domestic policy coordination.<br />

Country experiences in ensuring national policy coherence with<br />

respect to trade liberalization in the domain of health services include<br />

establishing inter-ministerial committees, appointing dedicated staff<br />

in ministries of health to work on trade issues <strong>and</strong> in ministries of<br />

trade/commerce to work on health issues, consultation with<br />

stakeholders, developing the research <strong>and</strong> evidence base, <strong>and</strong><br />

technical cooperation with international organizations.


WHO <strong>and</strong> WTO collaboration to support successful policy<br />

coherence has included high-level policy consultations, governance<br />

meetings, research <strong>and</strong> analysis, country missions, regional/national<br />

meetings, training courses <strong>and</strong> informal consultations.<br />

To achieve trade <strong>and</strong> health policy coherence for human<br />

development, governments need to: develop a common<br />

underst<strong>and</strong>ing of the key trade <strong>and</strong> health policy issues through<br />

ongoing dialogue; have a clear commitment <strong>and</strong> ministry of health<br />

leadership to work towards trade <strong>and</strong> health policies that mutually<br />

support human development objectives; create sustainable<br />

institutional mechanisms to enhance coherence <strong>and</strong> use innovative<br />

instruments <strong>and</strong> appropriate incentives; ensure early <strong>and</strong> effective<br />

stakeholder involvement, build trust <strong>and</strong> recognise the importance of<br />

transparency; get the evidence right, develop costing <strong>and</strong> financing<br />

options, <strong>and</strong> propose alternatives; measure, track <strong>and</strong> evaluate<br />

progress, <strong>and</strong> make course corrections; <strong>and</strong> develop negotiation<br />

skills. The WHO website on globalization, trade <strong>and</strong> health<br />

(www.who.int/trade/) can support countries in these challenges.<br />

2.5 Discussion on presentations<br />

There was discussion about the possible conflict between<br />

liberalization <strong>and</strong> the ability to regulate the provision of health<br />

services at the national level. Globalization poses a credible threat to<br />

national health care systems, it was felt. So far there has been very<br />

little analysis of the costs associated with liberalization. The ‘right to<br />

health’ should be a guiding ‘lens’ to govern the liberalization process.<br />

The liberalization of health services can be looked at from two<br />

perspectives, the economic perspective <strong>and</strong> the health perspective,<br />

that are completely different in terms of the challenges <strong>and</strong><br />

opportunities posed. What should concern policy-makers is the<br />

health outcome of liberalization, <strong>and</strong> this should take precedence.<br />

It was felt that WHO should provide assistance to countries in<br />

the process of acceding to the WTO. There is a need to identify a few<br />

indicators by mode in order to evaluate the nature of the impact of<br />

liberalizing trade in health services on national health care systems.


20 Trade in health services in the <strong>Eastern</strong> <strong>Mediterranean</strong> <strong>Region</strong><br />

Other important issues include dispute settlement mechanisms <strong>and</strong><br />

how to operationalize them.<br />

The right to health should be a guiding principle with regards<br />

to the impact of globalization on health services, it was felt. However,<br />

so far the evidence has not been encouraging. The issue of human<br />

resources <strong>and</strong> the scarcities created as a result of the movement of<br />

health care professionals has become increasingly important. There is<br />

a possibility that governments’ are reducing their investment in<br />

medical services, in parallel to increased reliance on the private<br />

sector, both foreign <strong>and</strong> local. It was also noted that no country had<br />

scheduled commitments in the domain of health for a long enough<br />

time period to properly evaluate the nature of the impact created.<br />

The impact of former liberalizing efforts such as structural<br />

adjustment has shown that the costs may well be high <strong>and</strong> this calls<br />

for caution. A concise assessment of the benefits for a country of<br />

joining the WTO is needed. There is also a need for a more focused<br />

methodology with regards each particular mode of supply. The<br />

identification of priority areas in relation to trade <strong>and</strong> health services<br />

is required. When discussion of trade <strong>and</strong> health services takes place,<br />

the focus tends to be only on tertiary services, rather than on primary<br />

<strong>and</strong> secondary health care, the services that help the poor. There is<br />

therefore a need to evaluate how trade in health services can improve<br />

both primary <strong>and</strong> secondary health services. There is also a need to<br />

integrate the provision of these services at the regional level.<br />

Developing countries may be best advised to ‘wait <strong>and</strong> see’<br />

what the outcome of liberalization will be before committing.<br />

However, some felt that developing countries are best advised to<br />

schedule their commitments to reflect the status quo. That developed<br />

countries are refraining from opening up their health services sectors<br />

to the forces of globalization, should be taken as an indicator of the<br />

risks that may even go beyond the abilities of these countries.<br />

Negative examples have been seen of privatization in the social<br />

sectors. The health care sector has a different status to other of<br />

economic or social sectors, <strong>and</strong> this special status almost always<br />

negates free trade.


The nature of the assistance WTO is providing to developing<br />

countries in the domain of services trade liberalization was discussed.<br />

Apart from multilateral trade agreements, bilateral free trade<br />

agreements (FTAs) are also booming, so WTO advice to countries<br />

negotiating on FTAs is needed. It is important that countries are<br />

informed on rules-based negotiations.<br />

Commitments in services have proven to be positively linked to<br />

FDI flows <strong>and</strong> the quality of services, particularly for sectors such as<br />

telecommunications. However, in the case of health services, the<br />

situation has proven to be different, because of the sensitivity of the<br />

sector.<br />

When countries decide to schedule their commitments in any of<br />

the services sectors this ‘locks’ these commitments for increased<br />

credibility. WTO has seem some 100 trade disputes, but only two<br />

concerned services, indicating that GATS has worked more smoothly<br />

than any other agreement. However, small countries still have<br />

problems translating autonomous liberalization into commitments<br />

under the GATS framework, <strong>and</strong> this is where technical support is<br />

needed. WTO is just an umbrella organization, <strong>and</strong> the decision to<br />

commit is in the h<strong>and</strong>s of governments, with WTO being more like a<br />

notary. WTO can however provide technical assistance through<br />

various missions <strong>and</strong> seminars. The Aid for Trade initiative adopted<br />

at the Hong Kong ministerial meeting is meant to help institution<strong>building</strong><br />

in developing countries.<br />

It was pointed out that regional <strong>and</strong> bilateral trade agreements<br />

should be notified to WTO. In these agreements countries give more<br />

than in the MFN approach <strong>and</strong> with no safeguards. The extent to<br />

which bilateral <strong>and</strong> regional trade agreements take countries away<br />

from the GATS agenda was noted. However, FTAs have become an<br />

important foreign policy issue.<br />

The WTO negotiations process was discussed from an equity<br />

perspective. The role of government in the health care sector in<br />

relation to both globalization <strong>and</strong> liberalization was raised, because<br />

the market has been shown to fail in the health sector. Countries<br />

should not rush to liberalize as there is no conclusive evidence


22 Trade in health services in the <strong>Eastern</strong> <strong>Mediterranean</strong> <strong>Region</strong><br />

regarding impact. There is a need to carry out more studies on trade<br />

<strong>and</strong> health in relation to liberalization under the multilateral<br />

framework <strong>and</strong> a need to analyse these results within the context of<br />

national policy objectives. Countries need to ensure that the benefits<br />

from trade in health services trickle down to the poor. At this early<br />

stage it is not possible to describe clear benefits.<br />

However, countries are under increased pressure to liberalize,<br />

<strong>and</strong> therefore may not be able to ‘wait <strong>and</strong> see’. There is therefore a<br />

need to feed the results of the country studies undertaken by the<br />

<strong>Region</strong>al Office into the policy debate through national policy forums<br />

on trade <strong>and</strong> health.<br />

3. <strong>Region</strong>al experience in trade in health services<br />

3.1 Methodological framework for assessing trade in health<br />

services<br />

Azza El Shinnawy<br />

The lack of information regarding the nature <strong>and</strong> extent of trade<br />

in health services <strong>and</strong> the risks <strong>and</strong> opportunities associated with<br />

each of the modes of supply, as well as the limited research <strong>capacity</strong><br />

in academic institutions for undertaking research on trade in health<br />

services, was the driving force behind the WHO, IDRC <strong>and</strong> UNFPA<br />

Concerted Action for <strong>Research</strong> <strong>and</strong> Capacity Building in Trade in<br />

Health Services in the <strong>Eastern</strong> <strong>Mediterranean</strong> <strong>Region</strong>.<br />

The core components of the methodological approach included<br />

a review of the overall macroeconomic <strong>and</strong> trade environment <strong>and</strong><br />

the domestic health system to provide the contextual basis for the<br />

assessment of trade in health services. Among the key issues<br />

investigated were: whether trade liberalization is part of the country’s<br />

development strategy; the trends <strong>and</strong> regulation of FDI; the<br />

organization <strong>and</strong> financing of the health care system; the major health<br />

care challenges of the country; <strong>and</strong> possible sources of information.<br />

Under each of the supply modes, detailed questions were posed<br />

addressing the current status of trade in the mode, existing <strong>and</strong><br />

proposed GATS commitments in the mode, national policy in relation


to the mode <strong>and</strong> the regulatory regime for the mode. For example, for<br />

mode 1, questions addressed the current status of trade in mode 1,<br />

existing or proposed GATS commitments under mode 1 in health<br />

services, national policy on e-Health, the nature of the infrastructure<br />

<strong>and</strong> regulatory <strong>capacity</strong>, the regulatory regime for e-Health <strong>and</strong> the<br />

situation of information technology (IT) infrastructure. A note about<br />

data availability <strong>and</strong> sources of information for each mode was also<br />

included.<br />

An important part of the methodological approach was the<br />

review of national legislation <strong>and</strong> the regulatory framework<br />

governing trade in health services under the four modes of supply in<br />

order to identify the market access conditions that are in place as well<br />

as exemptions to national treatment. The methodological framework<br />

also presented a list of possible sources from which to collect<br />

information <strong>and</strong> data regarding estimates of the value <strong>and</strong> direction<br />

of trade in health services with respect to the four modes of supply<br />

under GATS.<br />

One of the core components of the methodological framework<br />

was the analysis <strong>and</strong> assessment of the level of country commitments<br />

for providing <strong>and</strong>/or seeking market access to health services, as well<br />

as an assessment of the challenges <strong>and</strong> opportunities posed by the<br />

liberalization of trade on the provision of health services <strong>and</strong> options<br />

for national policy-makers.<br />

The matrix of challenges <strong>and</strong> opportunities presented in the<br />

methodological framework was the basis for the analytical part of the<br />

country case-studies. The matrix presented a check list of possible<br />

implications of liberalising trade in health services which formed the<br />

basis for advising policy-makers on the pace <strong>and</strong> scope of<br />

liberalization under the GATS framework.<br />

Some key questions considered include:<br />

• How will GATS legally affect the country’s health policy?<br />

When, <strong>and</strong> how best, might negotiations be undertaken?<br />

• What is the single most important issue in determining whether<br />

to commit under GATS?


24 Trade in health services in the <strong>Eastern</strong> <strong>Mediterranean</strong> <strong>Region</strong><br />

• How might a country best obtain the information necessary to<br />

inform policy?<br />

Discussion<br />

The idea that trade in health services is a governance issue of<br />

national security was discussed, as was the concept of global health<br />

governance <strong>and</strong> the leading role of WHO within this. The need for<br />

health systems to put their “house in order” in order to mitigate the<br />

bad effects of trade in health services was also discussed.<br />

The costs <strong>and</strong> benefits of joining or not joining the GATS were<br />

discussed. It was noted that the status of newly acceded members’<br />

(like Oman <strong>and</strong> Jordan) is different from that of the older members.<br />

However, while commitments may be made under pressure <strong>and</strong><br />

countries have to “pay” a lot, non-members are excluded from tariff<br />

reductions except through bilateral/regional agreements. It was<br />

explained that GATS allows countries to specify what they want to<br />

commit on <strong>and</strong> that health services can be excluded. It was noted that<br />

there are also bilateral/regional agreements that exist outside the<br />

WTO framework <strong>and</strong> it was clarified that Sudan <strong>and</strong> Yemen are<br />

currently under accession to WTO.<br />

The methodology used in the country case-studies was<br />

discussed <strong>and</strong> it was felt that there is a need to investigate trade in<br />

health services in terms of its impact on health services as well as on<br />

the determinants of health (including poverty <strong>and</strong> economic growth).<br />

It was noted that there has not yet been enough time to assess the<br />

impact on health, which could take many years to measure.<br />

It was felt that the focus should be on obtaining evidence that<br />

trade liberalization is good for health <strong>and</strong> that in the absence of such<br />

evidence it would be best for countries to adopt a “wait <strong>and</strong> see”<br />

approach to GATS. However, it was pointed out that trade in health<br />

services was already happening before GATS <strong>and</strong> therefore there is<br />

no new impact issue. A key question to address, it was suggested, is<br />

whether “open” or “non-open” health systems perform better. To<br />

measure this, indicators are required (by Mode) for openness <strong>and</strong>


performance. There is a need to focus on the impact in specific areas<br />

of concern; in this regard, a country-focus on different areas could be<br />

useful.<br />

It was explained that the methodology book had been refined<br />

<strong>and</strong> adapted for the <strong>Region</strong> from a WHO headquarters version, <strong>and</strong><br />

included a set of questions on health context, trade <strong>and</strong> health policy.<br />

The methodology was defined to encourage analysis <strong>and</strong><br />

interpretation, as well as policy recommendations, not just data<br />

collection. It was observed that the issue was not just one of asking<br />

the right questions but is also about identifying the right sources for<br />

the answers, of which there are many, often outside the Ministry of<br />

Health. There is no single source or nodal point, <strong>and</strong> this necessitates<br />

initiative.<br />

It was felt that the methodology needed to take into account the<br />

position of he different stakeholders, including hospitals, consumers,<br />

health insurance, physicians etc. It was noted that some countries,<br />

such as Malaysia, have done this <strong>and</strong> that some have set up websites<br />

to support the process. There are also conceptual issues that need to<br />

be further addressed, such as under which Mode to categorize some<br />

health services (for instance, visiting medical teams in Sudan). A<br />

concept workshop could help to improve the conceptual basis of the<br />

methodology. It was acknowledged that the methodology is a<br />

working methodology <strong>and</strong> will be further refined.<br />

3.2 Challenge of assessing trade in health services: experience from<br />

the <strong>Eastern</strong> <strong>Mediterranean</strong> <strong>Region</strong><br />

Dr Sameen Siddiqi<br />

The <strong>Eastern</strong> <strong>Mediterranean</strong> <strong>Region</strong> covers 22 countries <strong>and</strong> has<br />

a population of approximately 500 million. The proportion of the<br />

population aged less than 15 years is 40% <strong>and</strong> the dependency ratio is<br />

79%. Overall, the <strong>Region</strong> is a low middle-income region with a GNP<br />

per capita of US$ 1700 <strong>and</strong> contains five of the least developed<br />

countries. The <strong>Region</strong> faces several challenges in the area of trade in<br />

health services:<br />

• a lack of underst<strong>and</strong>ing <strong>and</strong> information on the nature <strong>and</strong><br />

extent of trade in health services;


26 Trade in health services in the <strong>Eastern</strong> <strong>Mediterranean</strong> <strong>Region</strong><br />

• limited research <strong>capacity</strong> of institutions;<br />

• the need to place trade in health services on the health policy<br />

agenda <strong>and</strong> evolve a planned response;<br />

• the need to assess the implications of trade in health services on<br />

public health;<br />

• the need for countries to develop strategies to both protect the<br />

public health interest <strong>and</strong> maximize the benefits of trade<br />

liberalization.<br />

Pakistan, Sudan <strong>and</strong> Yemen are low-income countries. All<br />

three, by <strong>and</strong> large, promote market-driven policies, liberalization<br />

<strong>and</strong> deregulation <strong>and</strong> favour an open trade regime. All have liberal<br />

laws to encourage foreign investment <strong>and</strong> all underwent World Bank<br />

<strong>and</strong> International Monetary Fund-led stabilization <strong>and</strong> structural<br />

adjustment programmes in the 1990s. For the middle <strong>and</strong> upper<br />

middle-income countries of Egypt, Jordan, Morocco, Oman, Syrian<br />

Arab Republic <strong>and</strong> Tunisia there has been a progressive shift from an<br />

over-regulated to a market-oriented economy since the 1980s,<br />

progressive trade liberalization, encouragement for FDI, free trade<br />

agreements with other Arab countries <strong>and</strong> neighbours, <strong>and</strong> a reliance<br />

on services sectors, especially tourism <strong>and</strong> foreign remittances. In the<br />

Syrian Arab Republic there have been trade protectionist policies<br />

with strong central planning. Lebanon has long had a liberal trade<br />

regime, promoting extensive privatization, even in the social sectors,<br />

<strong>and</strong> banking <strong>and</strong> tourism are the leading services sectors.<br />

Table 2 provides an overview of the state of the domestic health<br />

sector in the countries studied, while table 3 gives a summary of their<br />

membership status <strong>and</strong> schedule of commitments to GATS in the<br />

health sector.


Table 2. State of health sector in country studies<br />

Areas Low income countries Lower middleincome<br />

countries<br />

Upper middleincome<br />

countries<br />

Governance Limited <strong>capacity</strong> for evidence-based policy formation <strong>and</strong> strategic<br />

planning<br />

Inadequate <strong>capacity</strong> to legislate, regulate <strong>and</strong> enforce rules <strong>and</strong><br />

regulations<br />

Financing Inadequate allocation<br />

to health<br />

High share of out-ofpocket<br />

payment<br />

Absence of social<br />

health insurance<br />

programmes<br />

Human<br />

resource<br />

development<br />

Service<br />

provision<br />

Health<br />

information<br />

Poor <strong>capacity</strong> for<br />

human resources<br />

planning<br />

Inappropriate skill mix<br />

Lack of trained health<br />

<strong>and</strong> hospital managers<br />

Accreditation system<br />

not functional<br />

Primary health care not<br />

universally accessible,<br />

basic package of health<br />

services absent<br />

Weak district health<br />

system, poorly<br />

functioning drug<br />

supply/referral systems<br />

Inadequate recognition<br />

of private sector role<br />

Poorly functioning<br />

management<br />

information systems<br />

Burden of<br />

disease/national health<br />

account not assessed<br />

Limited <strong>capacity</strong> for<br />

health services research<br />

Absence of<br />

universal coverage<br />

High share of outof-pocket<br />

payment<br />

Inefficient social<br />

health insurance<br />

programme<br />

Poor <strong>capacity</strong> for<br />

human resources<br />

planning<br />

Inappropriate skill<br />

mix<br />

Deficient cadre of<br />

health managers<br />

Accreditation<br />

system not fully<br />

functional<br />

Inadequate<br />

scheme for<br />

universal coverage<br />

of expatriates<br />

Heavy reliance on<br />

expatriate human<br />

resources<br />

Policies that<br />

promote national<br />

health workforce<br />

Inadequate focus of primary health care<br />

programmes on quality, responsiveness<br />

to changing burden of disease <strong>and</strong><br />

needs of aging population<br />

Escalating costs of health care/<br />

medicines<br />

Weak regulation of investment in<br />

complex centres, inappropriate use of<br />

technology<br />

Management information systems<br />

needs strengthening<br />

Burden of disease/national health<br />

account not institutionalized<br />

Limited <strong>capacity</strong> for health services<br />

research


28 Trade in health services in the <strong>Eastern</strong> <strong>Mediterranean</strong> <strong>Region</strong><br />

Table 3. WTO membership status <strong>and</strong> schedule of commitments to<br />

GATS in health sector<br />

Country Medical <strong>and</strong><br />

dental services<br />

Nurses,<br />

midwives,<br />

etc.<br />

Hospital<br />

services<br />

Other<br />

human<br />

health<br />

services<br />

Egypt X<br />

Jordan X X X X X<br />

Lebanon In process of accession to WTO/observer status<br />

Morocco No commitment in health sector<br />

Oman X X<br />

Pakistan X X<br />

Sudan In process of accession to WTO/observer status<br />

Syrian Arab<br />

Republic<br />

Not a WTO member<br />

Tunisia No commitment in health sector<br />

Yemen In process of accession to WTO/observer status<br />

Notes X = commitments made<br />

∗ = includes heath insurance, professional services<br />

Other<br />

relevant<br />

health<br />

sectors∗<br />

In terms of the overall status of the trade in health services for<br />

the four modes of supply in the case-study countries, none of the<br />

countries had a well developed tele-health services programme under<br />

mode 1 (cross-border supply). However, the Ministry of<br />

Communication <strong>and</strong> the Ministry of Health <strong>and</strong> Population in Egypt<br />

have recently launched a large initiative to develop the first telemedicine<br />

network.<br />

Mode 2 (consumption abroad, popularly called “medical<br />

tourism”) is important in the <strong>Region</strong> with many countries being net<br />

exporters <strong>and</strong> others net importers of health services. For instance,<br />

patients travel in large numbers from Yemen <strong>and</strong> Sudan to consume<br />

health care aboard, while Jordan is the leading promoter of medical<br />

tourism in the <strong>Region</strong>; 120 000 patients sought medical services in<br />

Jordan in 2002, generating an estimated revenue of US$ 620 million.


For mode 3 (foreign commercial presence), in 2004, foreign<br />

direct investment in Jordan’s hospital sector reached US$ 8.6<br />

million. Foreign investors are treated equally with Jordanians in<br />

terms of all rights <strong>and</strong> privileges awarded, except that non-<br />

Jordanians need to deposit bank drafts of no less than JD 50 000.<br />

Examples of FDI are also common in Egypt, such as the Dar-El-Fouad<br />

Hospital, which has a large foreign equity holding, <strong>and</strong> the Al-<br />

Maghraby hospitals <strong>and</strong> centres. In Pakistan, the Shifa International<br />

Hospital in Islamabad is an investment by Pakistani Americans.<br />

There was no evidence of FDI in health so far in Morocco, Oman,<br />

Sudan <strong>and</strong> the Syrian Arab Republic.<br />

In mode 4 (movement of natural persons) Egypt, Jordan,<br />

Pakistan, Sudan <strong>and</strong> Tunisia are net exporters of health workforce,<br />

while Oman, like all Gulf Cooperation Council countries, is a net<br />

importer.<br />

There is lack of policy coherence between ministries of trade<br />

<strong>and</strong> ministries of health in most countries. The Ministry of Commerce<br />

in Pakistan has a special WTO wing but collaboration with the<br />

Ministry of Health is weak. Oman has established a Higher<br />

Committee for WTO issues <strong>and</strong> the Ministry of Health is a permanent<br />

member, while in Jordan the Ministry of Health works closely with<br />

the Ministry of Industry <strong>and</strong> Trade <strong>and</strong> the Ministry of Tourism <strong>and</strong><br />

Antiquities to promote medical tourism.<br />

The lessons learnt from undertaking the case-studies can be<br />

summarized as follows: public health professionals need to learn the<br />

trade jargon <strong>and</strong> underst<strong>and</strong> trade <strong>and</strong> health issues before<br />

embarking on studies; the methodological framework is a useful<br />

guide to undertaking trade in health services studies, but innovation<br />

is required while collecting data; it is critical to share trade in health<br />

services messages with national policy-makers; <strong>and</strong> analysis of trade<br />

in health services should address how to ensure that public health<br />

interests are not compromised in favour of trade liberalization.<br />

In conclusion, most countries of the <strong>Region</strong> have an explicit<br />

trade liberalization policy which impacts on health services. Modes 2<br />

<strong>and</strong> 4 are currently the most important modes of trade in health


30 Trade in health services in the <strong>Eastern</strong> <strong>Mediterranean</strong> <strong>Region</strong><br />

services in the <strong>Region</strong>. However, it is important to note that most<br />

trade in health services in the <strong>Region</strong> takes place outside GATS. It is<br />

essential that there is policy coherence among the ministries of health<br />

<strong>and</strong> ministries of trade in partnership with civil society. Finally,<br />

despite the limited data, health policy-makers now have greater<br />

awareness of the public health implications of trade in health services<br />

<strong>and</strong> GATS.<br />

3.3 Egypt<br />

Azza El-Shinnawy<br />

Egypt is the second largest economy in the Middle East <strong>and</strong><br />

North Africa after Saudi Arabia, with a GDP of 594 billion Egyptian<br />

Pounds (LE) (US$ 104 billion). It is classified as a lower middleincome<br />

economy <strong>and</strong> is one of the most densely populated countries<br />

of the <strong>Region</strong>. Egypt is a labour surplus economy, <strong>and</strong> is a major<br />

exporter of labour services to the <strong>Region</strong>. Some 1.9 million Egyptians<br />

are working abroad as temporary migrants. The Egyptian economy is<br />

also a service dominated economy, whereby services account for<br />

close to 47% of GDP.<br />

Despite Egypt’s commitments in several of the services sectors<br />

under the framework of the GATS, significant liberalization in the<br />

services sector has yet to materialize. Given the low sector coverage<br />

of commitments, <strong>and</strong> the relatively restrictive measures which apply<br />

to foreign commercial presence <strong>and</strong> natural persons in the scheduled<br />

sectors, a commitment to full service liberalization is not evident.<br />

Under the current stage of liberalization within the GATS<br />

framework, Egypt did not schedule health services in the Revised<br />

Conditional Offer. In the previous offer, only the health insurance<br />

sector was opened.<br />

It is difficult at this stage to quantify the exact magnitude of<br />

trade in health care services under mode 1. However, many hospitals<br />

surveyed had contracts with medical centres aboard to provide<br />

consultations through electronic mediums.<br />

With regards to mode 2, medical tourism is estimated to<br />

account for 2.5% of all incoming tourists to Egypt (4.3 million). As for<br />

Egyptian patients treated aboard (at government expense), the


numbers have gone down from 854 in 1994 at a total cost of LE 57<br />

million, to 240 in 2004, at a total cost of LE 20 million, reflecting an<br />

import substitution policy in this domain.<br />

Medical students studying in Egypt at national universities<br />

account for 8.1% of all foreign students (6000), while dentistry<br />

students account for 3.9% (2001/2002). Students from Arab countries<br />

account for 92% of all foreign students in Egypt. In private<br />

universities, the number of total foreign students has reached 4600,<br />

accounting for 28% of the student body: 25% study dentistry, 16%<br />

study medicine <strong>and</strong> 5.5% study pharmacy. Arabic studies accounts<br />

for 98% of foreign students in private universities.<br />

With regards mode 3, the current regulatory framework in<br />

Egypt is very liberal. Investment Law 8/1997 provided generous fiscal<br />

incentives to foreign investors to operate within the domain of<br />

hospital services (provided that 10% of <strong>capacity</strong> is available free).<br />

There is no ceiling on foreign equity share, no restrictions on l<strong>and</strong><br />

acquisition (except agricultural l<strong>and</strong>) <strong>and</strong> no ceiling on the number of<br />

foreign employees. The outcome has been a significant inflow of<br />

capital (foreign <strong>and</strong> local) in Egypt’s hospital sector.<br />

As for mode 4, which is of particular importance to Egypt<br />

according to the Egyptian Ministry of Manpower, Employment <strong>and</strong><br />

Immigration, health care services, including physicians <strong>and</strong> nurses,<br />

are among the most sought-after professions in neighbouring Arab<br />

countries. With regards to foreign professionals practicing in Egypt,<br />

Law 70/1996 regulates the provision of diagnostic <strong>and</strong> treatment<br />

services by foreigners in Egypt. The law clearly outlines the<br />

conditions under which private <strong>and</strong> public hospitals or clinics are<br />

allowed to utilize the services of foreign health professionals. Prior<br />

authorization is needed from the Ministry of Health <strong>and</strong> Population,<br />

based on the precondition that the service provider holds a<br />

distinguished track record in his/her domain <strong>and</strong> that no such<br />

expertise is available locally. The contract with the service provider<br />

cannot extend beyond three months <strong>and</strong> he/she cannot have a permit<br />

to work twice in Egypt during a single year. In 2005, 71 foreign<br />

medical experts provided their services in Egypt.


32 Trade in health services in the <strong>Eastern</strong> <strong>Mediterranean</strong> <strong>Region</strong><br />

3.4 Jordan<br />

Dr Riyad Amin Okour <strong>and</strong> Dr Ratib Hinnawi<br />

The total population of Jordan is 5.35 million (2004), with a<br />

population growth rate of 2.8%. The proportion of people over 65 has<br />

been increasing <strong>and</strong> is expected to reach nearly 4% of the total<br />

population by 2015.<br />

Health care services in Jordan are provided by a complex<br />

amalgam of providers, mainly in the public sector, which includes the<br />

Ministry of Health, the Royal Medical Services <strong>and</strong> two university<br />

hospitals. The Ministry of Health provides primary, secondary <strong>and</strong><br />

tertiary services through a network of health centres, maternal <strong>and</strong><br />

child health centres, <strong>and</strong> hospitals. It runs 29 hospitals distributed<br />

throughout the country with 3500 beds, representing a third of<br />

hospital beds in the country.<br />

In 2001, total health care expenditure was estimated to be 598<br />

million Jordanian Dinars (JD), which accounted for 9.6% of GDP:<br />

public health care expenditure was 3.5% of GDP, while private health<br />

expenditure was 5.6% of GDP. Per capita health care expenditure was<br />

JD 115.4. Public sector health expenditure accounted for 45.0% of total<br />

health expenditure, private 48.7%, UNRWA 1.3% <strong>and</strong><br />

nongovernmental organizations 5.1%. The total (private) out-ofpocket<br />

expenditure on health was JD 242 million in 2001. The<br />

Ministry of Health is the major provider <strong>and</strong> financing agent within<br />

the public health system.<br />

With regards to trade in health services, mode 1 is practiced in<br />

Jordan on a limited scale. In the public sector it is not practiced yet,<br />

but the Ministry of Health is planning to utilize telemedicine. The<br />

Ministry has limited programmes on e-health <strong>and</strong> e-learning in<br />

selected areas of Jordan, but this experience is still in its first stages,<br />

<strong>and</strong> data are not yet available.<br />

In mode 2, Jordan has a reputable health care system <strong>and</strong> the<br />

private sector has gained a reputation as a centre of excellence for<br />

many subspecialties including cardiovascular surgery,<br />

transplantation, plastic surgery <strong>and</strong> cancer treatment. Reliable data<br />

on the extent of movement of Jordanian nationals for health services


abroad is difficult to obtain. Patients are covered by the Ministry of<br />

Health insurance scheme. During 2003, 32 cases were treated abroad<br />

at a total cost of US$ 1 million. These cases were treated mainly in the<br />

USA <strong>and</strong> UK.<br />

With regards to medical tourism in Jordan, over 100 000 non-<br />

Jordanian Arab patients are treated annually in Jordanian medical<br />

institutions, particularly in the highly advanced fields of coronary<br />

care <strong>and</strong> kidney, brain <strong>and</strong> eye surgery. Yearly revenues from visiting<br />

patients varied from JD 450 million to JD 500 million between 2000<br />

<strong>and</strong> 2005. In terms of the nationality of patients, Yemenis account for<br />

30%, Libyans for 20%– 25% <strong>and</strong> Sudanese for 20%. Other patients<br />

come from countries such as Algeria, Iraq, Palestine, Saudi Arabia<br />

<strong>and</strong> other GCC countries, <strong>and</strong> Tunisia.<br />

The success of Jordan in attracting this large number of patients<br />

in mainly attributed to the health system performance indicators that<br />

reflect a more advanced system with a physicians to population ratio<br />

that is much higher than other neighbouring Arab countries.<br />

Hospitals are also well-equipped with a high level of technology.<br />

Doctors’ fees for most medical procedures <strong>and</strong> other health care<br />

services are moderate <strong>and</strong> are cheaper than regional competitors by<br />

about 30%. Jordan also has medical cooperation protocols with<br />

Algeria, Libyan Arab Jamahiriya, Sudan <strong>and</strong> Yemen.<br />

Jordan's future strategy for medical tourism includes: attracting<br />

140 000 patients by 2010, including more Arab patients <strong>and</strong> other<br />

patients from Europe <strong>and</strong> Africa; promoting investment <strong>and</strong> high<br />

st<strong>and</strong>ards in the health care sector (hospitals, specialized health<br />

centres) to maintain the medical tourism industry; <strong>and</strong> increasing<br />

revenue from medical tourism to JD 1 billion.<br />

For mode 3, the market access limitations on trade in health<br />

services in Jordan include: one of the owners must be a physician<br />

except in a public limited company; at least three-quarters of<br />

physicians in any hospital or nursing/convalescent homes must be<br />

Jordanian nationals <strong>and</strong> at least half of all staff must be Jordanians;<br />

for other health services, especially medical laboratories, the director<br />

must be a Jordanian national; external investors are treated the same


34 Trade in health services in the <strong>Eastern</strong> <strong>Mediterranean</strong> <strong>Region</strong><br />

as Jordanians in terms of rights <strong>and</strong> privileges, although non-<br />

Jordanians should have bank draft of not less than JD 50 000; <strong>and</strong> in<br />

the hospital sector, foreign investors can have 100% property<br />

ownership.<br />

With regards to mode 4, there are no general restrictions on the<br />

temporary movement of labour from Jordan to other countries.<br />

However, due to recent concerns of labour shortages in public health<br />

care, especially in nursing <strong>and</strong> specialized medicine, the Ministry of<br />

Health has placed temporary restrictions on these groups moving<br />

abroad. There is concern about a permanent “brain drain”, especially<br />

given large incentives to work in countries such as the UK. It is<br />

difficult to assess the flow of money into Jordan as a result of<br />

remittances made by Jordanian professionals working abroad.<br />

It is recommended that Jordan: establishes units within the<br />

Ministry of Health to tackle the issues of trade in health services <strong>and</strong><br />

to strengthen the <strong>capacity</strong> of all professionals concerned; carries out<br />

more in-depth situation analysis for various aspects of trade <strong>and</strong><br />

investment in health services, preferably a survey at the national<br />

level, <strong>and</strong> secures the needed human <strong>and</strong> financial resources for this;<br />

ensures policy development, strategic planning, regulations <strong>and</strong><br />

legislation to manage <strong>and</strong> empower trade in health services;<br />

strengthens <strong>and</strong> promotes partnership among stakeholders, including<br />

the private sector, academia, nongovernmental, organizations, UN<br />

agencies (especially WHO) <strong>and</strong> other sectors such as commerce <strong>and</strong><br />

industry; raises awareness among health professionals, mid-level<br />

mangers <strong>and</strong> community leaders; benefits from opportunities offered<br />

by trade in health services such as generation of foreign exchange<br />

earnings for health services, creating opportunities for new<br />

employment <strong>and</strong> access to new technologies <strong>and</strong> economic<br />

remittances of health care personnel working abroad; <strong>and</strong> avoids or<br />

minimizes risks such as brain drain <strong>and</strong> diversion of resources from<br />

other health services through better regulation <strong>and</strong> wise decisionmaking.<br />

It is also recommended that the <strong>Region</strong>al Office initiates a<br />

regional forum on trade <strong>and</strong> health for the provision of guidance,


<strong>capacity</strong> <strong>building</strong>, regional networking <strong>and</strong> supporting different<br />

activities undertaken within the trade <strong>and</strong> health framework.<br />

3.5 Lebanon<br />

Dr Nabil Kronfol<br />

Lebanon has a population of 4 million, with an annual growth<br />

rate of 1.7%. There is an 89% literacy rate <strong>and</strong> a 15% unemployment<br />

rate. Total health expenditure is US$ 2 billion (12.3% of GDP), <strong>and</strong><br />

there is a per capita health expenditure of US$ 500. Public sources<br />

account for 18% of the total, households 70% <strong>and</strong> pharmaceuticals<br />

25%. Public providers include National Social Security Fund (26%),<br />

the Cooperative of Civil Servants (4.4%), the military (11.2%) <strong>and</strong><br />

Ministry of Health as the insurer of last resort/safety net (43%).<br />

With regards to trade in health services under mode 1, the<br />

following initiatives exist: World Care, MedNet, e-learning (Arab<br />

Open University, courses, conferences) <strong>and</strong> e-commerce (Euro-Med<br />

initiative to develop the legal <strong>and</strong> regulatory framework <strong>and</strong> to<br />

promote development of e-commerce).<br />

For mode 2, there are no restrictions on travelling abroad. In the<br />

past, a trend existed to seek care in the Syrian Arab Republic (tests,<br />

dental care). Active steps have been taken to support medical tourism<br />

by both the government <strong>and</strong> the private sector. The flow increased<br />

after September 2001 <strong>and</strong> there has been active marketing by<br />

hospitals. About 5% of patients are foreigners, mainly Syrian Arab<br />

Republic nationals <strong>and</strong> citizens of GCC countries.<br />

In relation to mode 4, there is a serious problem of nursing staff<br />

shortages <strong>and</strong> a lesser one for doctors. There are restrictions on<br />

medical doctors moving to Lebanon due to professional requirements<br />

that need to be met in order to practice. There is a moderate inflow of<br />

nurses from the Philippines.<br />

Recommendations for mode 1 include: improving the<br />

telecommunication infrastructure <strong>and</strong> internet access; promoting egovernment;<br />

establishing the legal framework for e-commerce;<br />

responding to security concerns; raising business awareness of the<br />

benefits of e-commerce; provision of academic programmes on ecommerce<br />

law; establishing programmes to assist in <strong>capacity</strong>


36 Trade in health services in the <strong>Eastern</strong> <strong>Mediterranean</strong> <strong>Region</strong><br />

<strong>building</strong>, encourage internet usage, improve IT skills <strong>and</strong> improve<br />

knowledge of customers/suppliers; health institution cooperation in<br />

the development of telemedicine <strong>and</strong> e-learning both nationally <strong>and</strong><br />

regionally; <strong>and</strong> health insurance involvement through development<br />

of telemedicine-based second medical opinions.<br />

Under mode 2, medical tourism has been encouraged in many<br />

countries of the <strong>Region</strong>, giving rise to health competition. It is<br />

recommended that there should be provision of quality medical care<br />

at competitive prices <strong>and</strong> recognition of the importance of pricing<br />

(flat rates, prospective payment modalities) to encourage the flow of<br />

patients <strong>and</strong> students to educational establishments in Lebanon.<br />

In terms of mode 3, FDI in the health sector has been small,<br />

unlike other sectors, <strong>and</strong> health insurance in the <strong>Region</strong> is still in the<br />

development stage. It is therefore recommended that government<br />

oversee good practices in this sector to protect the consumer.<br />

International competition ought to be encouraged to protect patient<br />

interests <strong>and</strong> FDI encouraged to enter into partnership with (or buy<br />

into) existing family-owned facilities. Listing establishments on the<br />

Beirut stock exchange should be considered.<br />

For mode 4, it is recommended that Lebanon should recognise<br />

that restrictive measures have not been helpful in any country. There<br />

is a need to produce a greater number of nurses, <strong>and</strong> to retain them<br />

through provision of better job opportunities <strong>and</strong> work conditions to<br />

minimize the “push" factors. However, new employment<br />

opportunities exist in the <strong>Region</strong> <strong>and</strong> human resources should be<br />

viewed as “movable assets”.<br />

3.6 Morocco<br />

Professor Lahcen Achy<br />

Morocco is a middle income country, where GDP per capita is<br />

less than US$ 1700 (2004). The population is more than 30 million, life<br />

expectancy at birth is almost 70 years, the maternal mortality ratio is<br />

227 per 100 000 live births <strong>and</strong> the under-five mortality rate is 48 per<br />

1000 live births. Total expenditure on health is almost US$ 60 per<br />

capita (more than 5% of GDP), while out-of-pocket payments<br />

(household direct payments) st<strong>and</strong> at 52% of total health expenditure.


Between 30%–35% of the population are covered by m<strong>and</strong>atory<br />

health insurance.<br />

Under mode 1, substantial efforts are needed to improve<br />

training about, <strong>and</strong> access to, electronic resources for health care<br />

professionals. Cross-border supply of health services is still in the<br />

experimental stage <strong>and</strong> the regulatory regime for e-commerce is<br />

currently in preparation. However, a draft law has been prepared to<br />

deliver full-scale e-commerce transactions. Morocco’s comparative<br />

advantages under mode 1 are largely based on geographical<br />

proximity with Europe, close linguistic <strong>and</strong> cultural ties with some<br />

European countries <strong>and</strong> the emerging “call centre” sector that is a<br />

good starting point for other IT-related services including e-health.<br />

Under mode 2, National Fund of Social Protection<br />

Organizations (CNOPS) data indicates that in 2001, 500 patients were<br />

sent abroad for specialized health care <strong>and</strong> surgical treatments;<br />

transfers to cover their health expenses amounted to US$ 2.25 million.<br />

Consumption of health services abroad declined between 1993 <strong>and</strong><br />

2002, with the share in total reimbursements by CNOPS declining<br />

from 32% in 1993 to 4% in 2002. France is the main destination of<br />

Moroccan patients seeking health care services abroad. Foreign<br />

exchange worth US$ 4.8 million has been legally transferred by<br />

institutions <strong>and</strong> individuals for health purposes (medical insurance<br />

amounting to 50% <strong>and</strong> the rest being mainly out-of pocket money).<br />

With regards to mode 3, the health sector is currently not open<br />

to FDI. Only physicians who have fulfilled the requirements for<br />

practicing medicine in Morocco may establish private clinics <strong>and</strong><br />

comparable medical facilities. Morocco has no commitment under<br />

foreign commercial services in health services. Insurance is an<br />

exception, but commitments were made under financial <strong>and</strong><br />

insurance services.<br />

Under mode 4, Morocco has made no commitments on the<br />

movement of health professionals. However, for foreigners to be able<br />

to practice in Morocco, they have to have permanent residency in<br />

Morocco, be the spouse of a Moroccan national or have a bilateral<br />

agreement with one, or have government authorization.


38 Trade in health services in the <strong>Eastern</strong> <strong>Mediterranean</strong> <strong>Region</strong><br />

Morocco is committed to the opening up of trade in health<br />

services <strong>and</strong> hence legislation should evolve to support this. Building<br />

<strong>capacity</strong> <strong>and</strong> fully underst<strong>and</strong>ing GATS provisions <strong>and</strong> the<br />

implications of any form of liberalization on the national health<br />

system are crucial prerequisites. A national forum on trade <strong>and</strong><br />

health is recommended to be established to provide an opportunity<br />

for all stakeholders to voice their interests <strong>and</strong> concerns, <strong>and</strong> identify<br />

areas of possible gains or losses that may arise with the opening up of<br />

trade in health services.<br />

3.7 Oman<br />

Dr Batool Jaffer Suleiman<br />

Oman is an upper-middle income country with a population of<br />

2 340 000, including 1 782 000 nationals. In 2003, GDP was 8302<br />

million Omani Rials (OR) <strong>and</strong> per capita GDP was OR 3547. Ministry<br />

of Health expenditure per capita was OR 73.4 <strong>and</strong> formed 5.4% of<br />

overall government expenditure.<br />

Over 95% of the population have access to the public health<br />

system, <strong>and</strong> services are free for all Omani nationals, government<br />

employees <strong>and</strong> some other categories. There is an annual registration<br />

charge of US$ 2.58 <strong>and</strong> a nominal outpatient department visit fee of<br />

US$ 0.52. Most private hospitals <strong>and</strong> clinics are local ventures.<br />

Oman became a member of the WTO on November 2000.<br />

Modes 2 <strong>and</strong> 4 are currently the two active modes of trade in health<br />

services in Oman. There are no commitments in GATS mode 1 which<br />

is in a very nascent stage, although tele-education <strong>and</strong> tele-medicine<br />

will start soon. However, under mode 2, there is an outward<br />

movement of consumers (students <strong>and</strong> patients). The government<br />

sponsors Omani patients for treatment abroad; in 2002, the treatment<br />

abroad rate was 22 per 100 000 population. Omani patients may also<br />

go abroad for special treatment at their own expense.<br />

In terms of mode 3, there is no clear evidence of FDI in the<br />

health sector. Foreign suppliers are allowed to establish a presence in<br />

Oman as long as there is an Omani share of at least 30%. Companies<br />

with foreign equity of up to 70% pay the same rate of taxation as<br />

wholly Omani-owned companies. There is a 20% limitation on


foreign personnel. As for mode 4, Oman continues to be a net<br />

importer of qualified health professionals <strong>and</strong> teachers, <strong>and</strong> there is<br />

import of health-related materials (drugs, vaccines, medical<br />

equipments, etc.). The attrition rate for Omani doctors st<strong>and</strong>s at 1%.<br />

It is recommended that additional financial resources are<br />

identified to help reduce the burden on the Ministry of Health<br />

through cost-sharing <strong>and</strong> that the salaries of Ministry of Health staff<br />

are improved in order to maintain a high quality health care system.<br />

Incentives should be provided to attract FDI <strong>and</strong> human resources to<br />

remote areas.<br />

The Ministry of Health should maintain data for all patients<br />

sent for treatment abroad (sponsored <strong>and</strong> non-sponsored) <strong>and</strong> the<br />

volume of FDI should be identified by maintaining information about<br />

the true owners of private sector health institutions. <strong>Research</strong> should<br />

be done on the value <strong>and</strong> volume of the current <strong>and</strong> expected modes<br />

of trade in health services.<br />

3.8 Pakistan<br />

Dr Zafar Mirza<br />

Pakistan is a low income country in which the share of trade in<br />

GDP is 15.5%. In 2004, more than 65% of exports were manufactured<br />

goods. Pakistan is one of the founding members of the GATT <strong>and</strong><br />

WTO, <strong>and</strong> the current trade policy formulation is based on marketdriven<br />

policies, liberalization <strong>and</strong> deregulation.<br />

More than 50% of the population is under 19 years of age <strong>and</strong><br />

around 30% people live in absolute poverty. Pakistan has the sixth<br />

largest burden of tuberculosis in the world, 25% of births are low<br />

weight <strong>and</strong> 65% of women of child-bearing age are anaemic. The ratio<br />

of public : private expenditure on health is 22 : 78.<br />

Pakistan's schedule of commitments under GATS covers 47<br />

activities which fall under 6 service groups, including health-related<br />

<strong>and</strong> social services.<br />

Pakistan has only made commitments under the hospital<br />

services sub-sector, which means that Pakistan is committed to allow<br />

private hospitals services to be established in Pakistan by foreign<br />

nationals/companies (mode 3). A mix of modes exists in the supply of


40 Trade in health services in the <strong>Eastern</strong> <strong>Mediterranean</strong> <strong>Region</strong><br />

medical <strong>and</strong> dental services. There is an overlap between hospital<br />

services, medical <strong>and</strong> dental services, <strong>and</strong> movement of natural<br />

persons as in most cases these are interdependent.<br />

Before the GATS commitments there existed an outflow of<br />

students <strong>and</strong> health professionals going abroad for studies/training<br />

<strong>and</strong> patients for treatment. A limited number of medical <strong>and</strong> allied<br />

students came to Pakistan from neighbouring countries, the Middle<br />

East <strong>and</strong> Africa.<br />

Capacity <strong>building</strong> needs to be done in the Ministry of Health on<br />

trade issues <strong>and</strong> in the Ministries of Commerce <strong>and</strong> Foreign Affairs<br />

on health policy issues. The Ministries of Health <strong>and</strong> Commerce need<br />

to work together, <strong>and</strong> national priorities need to be set clearly <strong>and</strong><br />

adhered to strongly. Before making any further GATS commitments,<br />

an equity-based impact analysis needs to be done. Further research is<br />

required in this area.<br />

3.9 Sudan<br />

Dr Mounif Babikar<br />

Sudan is in the process of acceding to the WTO. In the domain<br />

of health services, Sudan has offered to open the following services:<br />

• Medical <strong>and</strong> dental services: specialized medical services where<br />

no limitations were placed concerning national treatment or<br />

market access, except for commercial presence. Commercial<br />

presence is made subject to an economic needs test based on the<br />

availability of services in the location concerned. No<br />

commitments are made concerning the movement of natural<br />

persons.<br />

• Veterinary services: same as above.<br />

• Health related <strong>and</strong> social services: hospital services (private,<br />

for-profit only). Commitments concerning cross-border supply<br />

<strong>and</strong> movements of natural persons were not made.<br />

Establishment of hospitals is granted taking into account, inter<br />

alia, the degree of specialization, geographical spread <strong>and</strong> the<br />

medical needs of the location concerned.<br />

• Other human health services: Sudan has only made<br />

commitments on some <strong>and</strong> not all services listed under this


sector/sub-sector. No limitations are put on consumption<br />

abroad or commercial presence, but no commitments are made<br />

concerning cross-border supply <strong>and</strong> movement of natural<br />

persons.<br />

Opening up the health care sector will present the opportunity<br />

for improvement of service quality through increased competition<br />

<strong>and</strong> retention of trained nationals within the country by offering<br />

better employment opportunities. Savings could be made in the<br />

treatment, travel, accommodation <strong>and</strong> subsistence expenses that are<br />

presently shouldered by patients who receive treatment abroad <strong>and</strong><br />

their accompanying carers.<br />

However, there is the threat that primary health care may be<br />

marginalized if foreign commercial presence (mode 3) concentrates<br />

on private tertiary <strong>and</strong> secondary care that targets the wealthier<br />

segments of the population. Weak regulatory <strong>capacity</strong> could hinder<br />

achieving the health <strong>and</strong> development goals of health for all <strong>and</strong><br />

jeopardise poverty reduction. Public counterpart institutions will lose<br />

the protection that may be offered by government through subsidies<br />

<strong>and</strong> exemptions.<br />

In terms of mode 1, the national laboratory stopped sending<br />

diagnostic test samples abroad in 1994. However, there is high<br />

potential for trade in health services via the internet <strong>and</strong> electronic<br />

means.<br />

With regards to mode 2, during 2000–2003 total patients sent<br />

abroad for care via the Medical Commission reached 4758, but this<br />

mode has lost its significance mainly due to import substitution.<br />

Egypt <strong>and</strong> the United Kingdom were the major destinations until the<br />

1980s, but in the 1990s, trade patterns shifted towards Jordan which<br />

became the main trade partner, followed by Egypt <strong>and</strong> other minor<br />

European <strong>and</strong> Asian partners.<br />

Under mode 3, two types of institutions are currently present,<br />

Hawwasha (Chinese) hospitals located in Alamaratin, Khartoum,<br />

where 8 private hospitals are located, <strong>and</strong> Alhasry Hospital, in central<br />

Khartoum, an area burgeoning with private for-profit hospitals. This<br />

indicates that foreign commercial presence through FDI has in fact


42 Trade in health services in the <strong>Eastern</strong> <strong>Mediterranean</strong> <strong>Region</strong><br />

overcome the limitations placed by Sudan on specialized health<br />

services.<br />

As regards mode 4, the number of Sudanese health<br />

professionals working abroad has increased <strong>and</strong> their remittances<br />

may support national health expenditures directly through the social<br />

transfers they make to their families <strong>and</strong> indirectly by stimulating the<br />

economy through their investment <strong>and</strong> consumption activities. An<br />

indirect impact on the national health system will be the more<br />

diversified professional experience that these workers will bring with<br />

them on their return to Sudan.<br />

Doctors are the largest category of foreigner employed by<br />

public sector institutions; while a few foreign graduate nurses <strong>and</strong><br />

technicians are also found, no foreign general workers are employed<br />

in the public health sector. The largest category of doctors come from<br />

Arab countries (111) followed by Africans (41), Asians (18) <strong>and</strong><br />

Europeans (12). In the private sector, doctors also head the list, but<br />

the numbers <strong>and</strong> categories of other health personnel are<br />

proportionately more. Moreover, the private sector also employs<br />

foreign general workers.<br />

The offers that Sudan has made in specialized health services<br />

encourage greater commercial presence, especially given the<br />

favourable regulatory environment. The current status for mode 2<br />

indicates that Sudan may have a deficit in the consumption of<br />

treatment abroad but a surplus in consumption of medical<br />

educational services. An assessment of the import-substitution policy<br />

on consumption abroad needs to be made. Sudan seems to have a<br />

surplus in movement of natural persons; however the data is<br />

deficient, especially in value measurements of trade.<br />

3.10 Syrian Arab Republic<br />

Dr Mahmoud Dashash<br />

Universal health care in the Syrian Arab Republic is guaranteed<br />

by the Constitution, <strong>and</strong> the Syrian health care system is a mix of<br />

private <strong>and</strong> public provision. There has been an expansion of primary<br />

health care institutions focusing on preventive services, <strong>and</strong> medical


procedures are low in cost in comparison with neighbouring<br />

countries.<br />

Major health care challenges include health financing,<br />

reformulating the free health care policy to target free services to the<br />

poor <strong>and</strong> needy, increasing <strong>capacity</strong> <strong>and</strong> improving service quality,<br />

increasing current allocations to health to raise wages, making new<br />

investments, <strong>and</strong> assuming a strong regulatory role.<br />

Under mode 1, the ICT penetration rate is low (less than 10%),<br />

although a draft law to regulate e-commerce is under deliberation.<br />

There is no government agency with a direct m<strong>and</strong>ate to regulate ehealth<br />

<strong>and</strong> no data exists on e-health providers. Given low<br />

penetration <strong>and</strong> the absence of adequate infrastructure, it is likely<br />

that the volume of trade under mode 1 is negligible.<br />

N relation to mode 2, no data exists on financial resources spent<br />

on health education abroad <strong>and</strong> treatment abroad is likely to be<br />

limited due to affordability. There are no figures on the number of<br />

Syrians studying medicine abroad, although popular destinations<br />

include neighbouring Jordan <strong>and</strong> Lebanon, in addition to the<br />

European Union <strong>and</strong>, to a lesser extent, the USA.<br />

For mode 3, no data is available on the breakdown of inward<br />

FDI flows, but the majority is assumed to be in the oil <strong>and</strong> gas sector.<br />

There is no specific legislation regulating FDI in the health sector.<br />

In terms of mode 4, no statistics are available on the number of<br />

health care professionals working abroad, although the vast majority<br />

who do are there on a permanent or long-term basis. Popular work<br />

destinations for expatriate Syrians are the countries of the Arabian<br />

peninsular.<br />

As for foreign health care professionals in the Syrian Arab<br />

Republic, labour regulations make it very difficult for foreigners to<br />

obtain work permits, but exceptions are made for specializations that<br />

are not available in the country, although this is hard to prove. There<br />

are no published figures on the number of foreign nationals working<br />

in the Syrian health care system.<br />

Lack of data makes it difficult to assess the status of trade in<br />

health services in the Syrian Arab Republic, making it impossible to


44 Trade in health services in the <strong>Eastern</strong> <strong>Mediterranean</strong> <strong>Region</strong><br />

formulate an evidence-based negotiation strategy for their<br />

liberalization. The Ministry of Health has made improvements in<br />

administration of the health care system a priority. This includes<br />

implementing more efficient IT systems, introducing telemedicine<br />

<strong>and</strong> creating electronic health records.<br />

3.11 Tunisia<br />

Dr Noureddine Achour<br />

In 2004, life expectancy at birth was 73.4 in Tunisia, with a birth<br />

rate of 16.8/1000. Total expenditure on health was 6.2% of GDP in<br />

2004, at US$ 174 per capita, with 52.2% being government<br />

expenditure <strong>and</strong> 47.8% being private expenditure. The Tunisian<br />

health system is a mix of public <strong>and</strong> private provision.<br />

The health system is currently having to respond to the<br />

changing demographic, epidemiological <strong>and</strong> risk profile of the<br />

population, as well as to rising expectations, changes in medical<br />

technology, a fast growing private sector <strong>and</strong> the desire of<br />

government to exp<strong>and</strong> services <strong>and</strong> achieve universal health<br />

coverage. This has produced new responsibilities related to public<br />

health, health system reform <strong>and</strong> regulation. Tunisia has no specific<br />

commitments in health services under GATS.<br />

With regards to trade in health services under mode 1, there is<br />

limited usage of cross-boarder supply of medical services in Tunisia,<br />

mainly due to the high cost of installing <strong>and</strong> the limited <strong>capacity</strong> to<br />

use such services.<br />

In terms of mode 2, a total of 132 foreign patients were treated<br />

at a cost of US$ 3.2 million in Tunisia in 2003.<br />

Under mode 3, Tunisia has not yet achieved any significant<br />

progress with regards to foreign commercial presence in the health<br />

care sector. There is only one off-shore clinic in Djerba financed by<br />

local <strong>and</strong> French (majority) capital.<br />

With regards to mode 4, Tunisia exports health professionals to<br />

many countries (GCC <strong>and</strong> European countries). Foreign physicians<br />

recruited by the Ministry of Public Health are mainly from eastern<br />

Europe <strong>and</strong> China. There are also a small number of private<br />

physicians who are married to Tunisians.


3.12 Yemen<br />

Dr Zeinab El Bakri<br />

An application was made to join WTO in 1999, <strong>and</strong> Yemen has<br />

so far been granted observer status. The National Committee under<br />

the Ministry of Trade oversees preparation for Yemen’s accession. As<br />

Yemen is a least developed country, GATS articles requiring<br />

commitments on market access <strong>and</strong> national treatment do not apply<br />

immediately.<br />

The public health sector infrastructure has exp<strong>and</strong>ed<br />

tremendously since 1990. However, there is lack of operating funds,<br />

medical staff <strong>and</strong> a problem regarding the geographical disparity in<br />

facilities. Also, there is an inability to provide efficient <strong>and</strong> quality<br />

services or accessibility to the poor. As a result, a health sector reform<br />

strategy was initiated in 1998, although no major improvement in<br />

health situation is evident as yet.<br />

Yemen is a net importer in trade in health services. Existing<br />

health institutions, public or private, are not equipped or staffed to<br />

provide quality health care. The government promotes provision of<br />

health services through private sector <strong>and</strong> foreign investors, granting<br />

easy entry to foreign professionals. Mode 2 is of particular<br />

importance to Yemen, since a large number of patients travel to seek<br />

medical services abroad. The government facilitates <strong>and</strong> partially<br />

funds the movement of Yemeni patients to seek medical treatment<br />

abroad for complicated diseases.<br />

In relation to mode 3, Yemen has so far attracted the<br />

establishment of only small-sized Arab investment in the health<br />

sector despite the liberal <strong>and</strong> generous provisions of its recently<br />

amended investment law. Mode 4 mainly involves the movement<br />

into Yemen of foreign health personnel to either work in national<br />

health facilities, public <strong>and</strong> private, or in medical colleges of<br />

government universities. Yemen enjoys no comparative advantage or<br />

potential for exporting professional health services to other countries.<br />

The three main issues that concern this area are the absence of a<br />

well-established system of data collection on trade in health services,<br />

deficiency in the regulatory regime governing the external trade in


46 Trade in health services in the <strong>Eastern</strong> <strong>Mediterranean</strong> <strong>Region</strong><br />

health services <strong>and</strong> lack of rigorous study on the impact of each mode<br />

of trade in health services.<br />

3.13 Discussion on the country studies<br />

It was asked whether the studies met Ministry of Trade needs<br />

for information that would support GATS negotiations. It was felt<br />

that countries need to establish a database on the health sector first,<br />

before liberalizing. The current schedule of negotiation deadlines<br />

requires that this is done soon. There is therefore need for the quick<br />

dissemination of the research results of the ten country case.<br />

However, it was questioned whether the recommendations of the<br />

studies were based on strong enough data <strong>and</strong> provided a good<br />

enough basis for policy-making.<br />

Some felt that the studies seemed to describe trade in health<br />

services rather than the impact of trade in health services <strong>and</strong> GATS<br />

on health. There was a need to look beyond trade to questions about<br />

the access to, quality <strong>and</strong> price of health services. It was, however,<br />

noted that a dual system (public/private) already existed in countries,<br />

<strong>and</strong> that the question should rather be whether foreign suppliers will<br />

create or accentuate inequality. It was also noted that GATS will<br />

affect the future of trade in health services <strong>and</strong> not the situation that<br />

is described in the case-studies.<br />

It was felt that there was no evidence as yet on the impact of<br />

GATS on national public health objectives. The GATS system is<br />

currently taking shape <strong>and</strong> it would be important to see how to<br />

ensure that it was better geared to the objectives of the health sector,<br />

taking into account that the health sector is different from the<br />

commercial sector, with prominence given to issues of accessibility,<br />

affordability, equality <strong>and</strong> equity. In this regard, liberalization is not<br />

an end in itself, but rather health is the goal. Liberalization is a means<br />

that can have both negative <strong>and</strong> positive impact; it is therefore<br />

important to protect health if there is liberalization.<br />

Some felt that the data seemed to indicate that it is best not to<br />

rush into liberalizing until there is the evidence that countries are<br />

ready for it. However, it was pointed out that the study of trade in


health services <strong>and</strong> of liberalization needs to be differentiated. The<br />

evidence does not seem to be enough to support liberalization in this<br />

regard. The next step should be to assess the impact of trade in health<br />

services in the four Modes on health services.<br />

It was felt that despite the pressure on countries to liberalize<br />

their health sectors, they have the right to “wait <strong>and</strong> see” before<br />

committing. Countries can start by making commitments in the least<br />

controversial areas <strong>and</strong> take their time before committing on the<br />

other areas. Countries should ask why they need to commit in an<br />

area, how strong they are in it <strong>and</strong> what the impact will be. It was<br />

noted that newer countries are paying a higher “price” in<br />

commitments. There were questions around why those countries that<br />

have made commitments have made them <strong>and</strong> on their<br />

competitiveness in the various Modes.<br />

It was pointed out that it would not be the decision of the<br />

health sector whether to liberalize or not. However, the sector can<br />

assess the situation, identify opportunities <strong>and</strong> threats, <strong>and</strong> put<br />

policies in place to protect <strong>and</strong> improve health outcomes. The<br />

instruments to do these things need to be developed. The issue is one<br />

of how to make trade work to improve health outcomes, such as<br />

access.<br />

There was discussion on the potential opportunities <strong>and</strong> threats<br />

of trade in health services, including the possibility of recycling funds<br />

generated by health tourism into the public health system. It was<br />

noted that health tourism in Jordan earns money that goes towards<br />

the upgrading of the overall health system (both public <strong>and</strong> private),<br />

as well as into the economy, <strong>and</strong> also leads to improved technology<br />

<strong>and</strong> international st<strong>and</strong>ards in health services. However, it was<br />

pointed out that it could lead to a focus on tertiary care at the expense<br />

of secondary <strong>and</strong> primary care, sectors that are often weak in the<br />

<strong>Region</strong> but which provide the vast majority of health care in<br />

countries (<strong>and</strong> that could prevent cases that require more expensive<br />

tertiary care). The increasingly expensive cost of health technology<br />

<strong>and</strong> the issue of medical litigation as consumers go abroad for<br />

services were also noted.


48 Trade in health services in the <strong>Eastern</strong> <strong>Mediterranean</strong> <strong>Region</strong><br />

The need to take a regional approach was discussed, to ensure<br />

that different countries’ health services are coordinated so that they<br />

compliment rather than compete with each other. Money spent<br />

abroad on health services could be saved <strong>and</strong> spent on improving<br />

services within countries, or at least kept within the <strong>Region</strong>. In some<br />

cases, it was noted that there may be a “win—win” situation, such as<br />

the treatment of patients from GCC countries in Jordan. It was<br />

suggested that the country studies publication could incorporate an<br />

index of competitiveness of countries of the <strong>Region</strong> in the different<br />

Modes. This would be a useful platform for a regional approach.<br />

The issue of the comparability of the country case-studies was<br />

discussed. It was suggested that a balance needs to be struck between<br />

achieving uniformity for comparability <strong>and</strong> reflecting the diversity of<br />

the <strong>Region</strong>. It was noted that the data included in the studies covered<br />

only formal rather than the informal flows in trade in health services<br />

that would be needed to obtain a more complete picture. It was felt<br />

that there was a need for more data, especially quantitative data, <strong>and</strong><br />

a greater analysis of trends. Comparative analysis <strong>and</strong> categorization<br />

is required as countries are in different situations.<br />

It was pointed out that information has a cost <strong>and</strong> needs to be<br />

invested in. The case studies are just a beginning <strong>and</strong> the research is<br />

exploratory at this stage, seeking to raise awareness of the issues<br />

rather than providing hard evidence as yet. It was also observed that<br />

the availability of data varies. However, it was noted that the<br />

methodology guide would be very useful for other sectors.<br />

4. Working groups<br />

Participants were distributed in three groups based on<br />

language preference (Arabic, English or French) to permit greater<br />

interaction. Based on what they had discussed over the last three<br />

days, the groups were asked to identify priority areas <strong>and</strong> propose<br />

recommendations for Member States <strong>and</strong> WHO. The main<br />

recommendations proposed by the three groups were as follows:


• Trade in health services-related activities need to be<br />

institutionalized within the work of ministries of health <strong>and</strong> of<br />

trade through the establishment of trade <strong>and</strong> health units.<br />

• Resources are needed to move forward a trade <strong>and</strong> health<br />

services agenda within countries. This would require writing<br />

project proposals for submission <strong>and</strong> approaching funding<br />

agencies, for which technical assistance from WHO will be<br />

required.<br />

• Improved coordination within <strong>and</strong> between countries in the<br />

area of trade in health services can be achieved through the<br />

establishment of a network for sharing experiences <strong>and</strong><br />

exchange of information.<br />

• In-depth studies on specific modes of trade in health services<br />

relevant to countries should be undertaken. This will require<br />

further work on the development of assessment methodology<br />

for each mode of supply.<br />

• All stakeholders, including the professional orders, civil society<br />

<strong>and</strong> consumers should be mobilized to build consensus <strong>and</strong><br />

greater policy coherence in the area of trade in health services.<br />

• There is a need for more research, including econometric<br />

studies, beyond the descriptive studies that have so far been<br />

undertaken.<br />

• A trade <strong>and</strong> health unit should be established in the <strong>Region</strong>al<br />

Office that provides support to countries on all aspects of the<br />

area, including trade in health services.<br />

• WHO should continue dialogue with WTO to develop a<br />

common underst<strong>and</strong>ing <strong>and</strong> perspective on trade <strong>and</strong> health<br />

issues.<br />

• WHO should allocate additional recourses to support <strong>capacity</strong><br />

<strong>building</strong>, country studies <strong>and</strong> regional meetings on trade <strong>and</strong><br />

health issues.<br />

• WHO should allocate resources to a special programme on<br />

trade <strong>and</strong> health in its biennial plan


50 Trade in health services in the <strong>Eastern</strong> <strong>Mediterranean</strong> <strong>Region</strong><br />

• WHO should produce a regional publication on current work in<br />

the area, especially the country studies undertaken on trade in<br />

health services.<br />

• WHO should plan studies in future that measure the impact of<br />

WTO membership on health outcomes <strong>and</strong> objectives.<br />

Discussion<br />

It was suggested that trade in health services could be<br />

discussed at <strong>Region</strong>al Committee, possibly as a st<strong>and</strong>ing agenda item,<br />

to support regional coordination on the issue.<br />

A reservation was expressed that the language of the meeting<br />

had been in English, restricting the full participation of some<br />

attendees, particularly those from Francophone countries. It was<br />

requested that the issue of interpretation into French <strong>and</strong>/or Arabic be<br />

addressed in future gatherings.<br />

The next steps in the process were outlined as being: a<br />

workshop report; publication of the country case-studies; a policy<br />

briefing on trade in health services; <strong>and</strong> an article in a peer-reviewed<br />

journal. The need for a forum at country level to take the issues<br />

forward was raised. It was noted that the case-studies publication<br />

would be translated into Arabic <strong>and</strong> French. Attention was drawn to<br />

the availability of relevant WHO headquarters publications in French.<br />

Information on the case-studies <strong>and</strong> trade in health services would<br />

also be made available on the <strong>Region</strong>al Office’s Health System<br />

Observatory website (www.emro.who.int/healthobservatory) on<br />

health services in the <strong>Region</strong>, which could become a forum for<br />

networking.<br />

It was noted that the same approach was required at countrylevel,<br />

possibly within the broad framework of trade <strong>and</strong> health. It was<br />

essential that countries build <strong>capacity</strong> in the area, strengthen<br />

governance <strong>and</strong> develop their health system to meet the challenges<br />

<strong>and</strong> opportunities posed by trade <strong>and</strong> health, <strong>and</strong> more broadly by<br />

globalization. WHO country offices have a key role in supporting this


work, including facilitating coordination, <strong>capacity</strong> <strong>building</strong>, training<br />

<strong>and</strong> bringing together stakeholders.<br />

It was suggested that WHO Representatives could usefully<br />

provide the case-studies to Ministries of Health <strong>and</strong> discuss with<br />

Ministries of Trade. However, it was noted that focal points or<br />

taskforces within ministries <strong>and</strong> mechanisms of coordination would<br />

be more sustainable in many countries than the creation of new units,<br />

given existing <strong>capacity</strong>. The issues would affect all departments in<br />

Ministries of Health. The stewardship role of Ministries of Health<br />

needs to be strengthened. Bringing together studies on governance,<br />

public/private partnership, contracting <strong>and</strong> trade in health services<br />

could help in this respect.<br />

The utility of regional <strong>and</strong> country training seminars <strong>and</strong><br />

modules on the issue was expressed. Pre-conference training was<br />

noted as a cost-effective approach to be considered. The existence of<br />

WHO headquarters’ training modules, both web-based <strong>and</strong> face-toface,<br />

on globalization, trade <strong>and</strong> health was noted. The development<br />

of a critical mass of trained <strong>and</strong> experienced human resources<br />

(including trade negotiators) within the <strong>Region</strong> would be useful, as<br />

would be links to academic institutions. The experience that already<br />

exists within the <strong>Region</strong> was pointed out, for instance Egypt <strong>and</strong><br />

Pakistan’s experience in GATS negotiations <strong>and</strong> Jordan’s experience<br />

in coordination between ministries of health <strong>and</strong> trade. The useful<br />

role of WHO headquarters in sharing existing experience <strong>and</strong> best<br />

practice on the issue was noted, in helping countries to update<br />

legislation for instance. It was suggested that WHO could host a joint<br />

WHO/WTO meeting in the <strong>Region</strong> of representatives from Ministries<br />

of Health <strong>and</strong> Trade.<br />

It was observed that the opportunities provided by<br />

globalization had not been explored enough <strong>and</strong> that countries<br />

needed to address the challenges, given that the process was already<br />

occurring, by strengthening their health systems <strong>and</strong> making them<br />

more competitive, <strong>and</strong> in seeking to benefit from any comparative<br />

advantages.


52 Trade in health services in the <strong>Eastern</strong> <strong>Mediterranean</strong> <strong>Region</strong><br />

5. Recommendations<br />

To Member States<br />

1. The knowledge base about trade in health services should be<br />

further improved through additional research for each mode of<br />

supply.<br />

2. Trade in health services-related activities should be<br />

institutionalized within the work of ministries of health <strong>and</strong><br />

collaboration improved with ministries of trade <strong>and</strong> commerce<br />

so that public health priorities are protected during trade<br />

negotiations.<br />

3. National policy forums should be initiated bringing together all<br />

concerned stakeholders, including civil society <strong>and</strong> academia,<br />

to share information on trade in health services <strong>and</strong> to engage<br />

in policy dialogue.<br />

4. Resources should be mobilized in order to build <strong>capacity</strong> in the<br />

assessment of national needs, in negotiations skills <strong>and</strong> in<br />

policy dialogue <strong>and</strong> the updating legislation in relation to trade<br />

in health services.<br />

5. Methodological approaches should be developed <strong>and</strong><br />

implemented in order to assess the implications of trade in<br />

health services on access to health, equity, safety <strong>and</strong> public<br />

health, <strong>and</strong> to build national scenarios for trade in health<br />

services.<br />

To WHO<br />

6. Technical support should be mobilized in countries seeking<br />

help in various steps of accession negotiation <strong>and</strong><br />

implementation of GATS Agreement.<br />

7. Support should be provided to development of a database on<br />

trade in health services as part of the regional Health System<br />

Observatory <strong>and</strong> to facilitate the sharing of the knowledge<br />

among researchers <strong>and</strong> policy-makers in the <strong>Region</strong>.


8. A regional heath policy forum on trade in health services<br />

should be initiated to help promote strategic thinking among<br />

concerned parties in the <strong>Region</strong>.<br />

9. The research methodology for each mode of supply in health<br />

should be refined <strong>and</strong> national <strong>and</strong> regional tool kits developed<br />

to support a comprehensive assessment of overall situation in<br />

trade <strong>and</strong> health in the <strong>Region</strong> <strong>and</strong> to improve policy coherence<br />

on trade in health services.<br />

10. Capacity <strong>building</strong> should be supported in areas related to trade<br />

in health services using existing links with academic, research<br />

<strong>and</strong> public health institutions.


54 Trade in health services in the <strong>Eastern</strong> <strong>Mediterranean</strong> <strong>Region</strong><br />

Tuesday, 30 May 2006<br />

Annex 1<br />

Programme<br />

08:30–09:00 Registration<br />

09:00–10:30 Inaugural Session<br />

Message of Dr Hussein A. Gezairy,<br />

WHO <strong>Region</strong>al Director for the<br />

<strong>Eastern</strong> <strong>Mediterranean</strong><br />

Speech by H.E Minister of Health,<br />

Morocco<br />

Comments on behalf of IDRC <strong>and</strong><br />

UNFPA<br />

Objectives of the meeting<br />

Introduction of participants <strong>and</strong><br />

nomination of Chairpersons <strong>and</strong><br />

Rapporteurs<br />

1030–11:00 Globalization, trade <strong>and</strong> health:<br />

WHO perspective/Nick Drager<br />

11:00–11:30 Conceptual issues in trade in Health<br />

services/Sameen Siddiqi<br />

11:30–12:00 Methodological framework for<br />

assessing trade in health<br />

services/Azza El Shinnawy<br />

12:00–14:00 Discussion<br />

14:00–17:00 Country studies: Jordan, Lebanon,<br />

Morocco, Pakistan, Syrian Arab<br />

Republic<br />

Discussion<br />

Wednesday, 31 May 2006<br />

08:30–09:00 GATS <strong>and</strong> trade in health services:<br />

WTO perspective/Rudolf Adlung<br />

09:00–10:30 Panel discussion on trade


liberalization in health services <strong>and</strong><br />

on-going GATS negotiations<br />

10:30–14:00 Country studies: Egypt; Oman;<br />

Sudan; Tunisia; Yemen.<br />

Discussion<br />

14:00–14:30 The challenge of assessing trade in<br />

health services: An <strong>Eastern</strong><br />

<strong>Mediterranean</strong> <strong>Region</strong><br />

perspective/Sameen Siddiqi<br />

14:30–15:10 Trade <strong>and</strong> health: A tool kit for<br />

analysis <strong>and</strong> assessment of<br />

countries/Nick Drager<br />

15:10–15:30 How can health <strong>and</strong> trade objectives<br />

converge at the policy level/Azza El<br />

Shinnawy<br />

15:30–17:00 Group work<br />

Thursday, 1 June 2006<br />

08:00–10:30 Group work<br />

10:30–12:00 Group presentation <strong>and</strong> discussion<br />

12:30–13:00 Closing session


56 Trade in health services in the <strong>Eastern</strong> <strong>Mediterranean</strong> <strong>Region</strong><br />

EGYPT<br />

Walid El Nozhai<br />

Head, Central Department<br />

World Trade Organization<br />

Cairo<br />

Mr Gamal Abdul Rasheed<br />

First Secretary<br />

Trade Office<br />

Geneva<br />

Annex 2<br />

List of participants<br />

Azza El Shinnawy<br />

Development Studies Institute (DESTIN)<br />

London School of Economics<br />

London<br />

Dr Mohammed Tag El Din<br />

Director<br />

Arab Company for Trade <strong>and</strong> Medical Appliances<br />

Cairo<br />

JORDAN<br />

Dr Ratib Hanawi<br />

Ministry of Health<br />

Amman<br />

Dr Riyad Amin Okour<br />

Directorate of Health Economics<br />

Ministry of Health<br />

Amman


LEBANON<br />

Dr Walid Ammar<br />

Director-General<br />

Ministry of Public Health<br />

Beirut<br />

Dr Bahij Arbid<br />

Planning Expert<br />

Ministry of Public Health<br />

Beirut<br />

Dr Nabil Kronfol<br />

President<br />

Lebanese Health Care Management Association<br />

Beirut<br />

MOROCCO<br />

Professor Lahcen Achy<br />

Professor of Economics<br />

INSEA, Rabat Institutes<br />

Rabat<br />

Mr Hamid Bekkar<br />

Chef de la Division du Contentieux et Affaires Professionnelles<br />

Rabat<br />

Mr Abderrahim Chakour<br />

Chef de la Division des Industries Chimiques et Parachimiques<br />

Rabat<br />

Mrs Khadija Meshak<br />

Directeur de la Réglementation et du Contentieux<br />

Rabat


58 Trade in health services in the <strong>Eastern</strong> <strong>Mediterranean</strong> <strong>Region</strong><br />

Mrs Samira Yamani<br />

Chef du Service des Industries Chimiques<br />

Rabat<br />

Dr Abderrahmane Zahi<br />

Secretary General<br />

Fondation Hassan II pour les Marocains Residents a L’Etranger<br />

Rabat<br />

OMAN<br />

Mr Salah Nasser Al Muzahmi<br />

Director of Health Information <strong>and</strong> Statistics<br />

Ministry of Health<br />

Muscat<br />

Dr Batool Jaffer Suleiman<br />

Director of <strong>Region</strong>al Drug Use<br />

Ministry of Health<br />

Muscat<br />

PAKISTAN<br />

Mr Manzoor Ali Bozdar<br />

Deputy Drugs Controller<br />

Islamabad<br />

Mr Ahmad Mokhtar<br />

Section Office (WTO)<br />

Ministry of Commerce<br />

Islamabad


SUDAN<br />

Dr Muneef Abdelbagi Babkir<br />

Assistant Professor (Health Economics)<br />

University of Khartoum<br />

Khartoum<br />

Dr Mustafa Salih Mustafa<br />

Director<br />

Planning Health Directorate<br />

Khartoum<br />

SYRIAN ARAB REPUBLIC<br />

Dr Mahmoud Dachach<br />

Director<br />

Planning <strong>and</strong> International Cooperation<br />

Damascus<br />

TUNISIA<br />

Dr Hichem Abdessalam<br />

Director, Technical Cooperation Unit<br />

Ministry of Public Health<br />

Tunis<br />

Dr Noureddine Achour<br />

Director<br />

National Institute of Public Health<br />

Tunis<br />

Mr Jamel Eddine Torki<br />

Deputy-Director<br />

General Directorate of Economic <strong>and</strong> Commercial Cooperation<br />

Ministry of Commerce <strong>and</strong> H<strong>and</strong>crafts<br />

Tunis


60 Trade in health services in the <strong>Eastern</strong> <strong>Mediterranean</strong> <strong>Region</strong><br />

YEMEN<br />

Dr Ebtihaj Al Kamel<br />

Ministry of Public Health <strong>and</strong> Population<br />

Sanaa<br />

OTHER ORGANIZATIONS<br />

AFRICAN DEVELOPMENT BANK<br />

Dr Zeinab El Bakri<br />

Director<br />

Social Development Department<br />

Central <strong>and</strong> West <strong>Region</strong> (OCSD)<br />

Tunis<br />

UNITED NATIONS POPULATION FUND (UNFPA)<br />

Dr Faysal Abdel Gadir<br />

Representative<br />

Cairo<br />

Dr Tarek Morsy<br />

Project Officer<br />

Unit for Monitoring Population Activities<br />

Cairo<br />

WORLD BANK<br />

Dr Akiko Meada<br />

Health Sector Manager, MENA <strong>Region</strong><br />

Washington<br />

WORLD TRADE ORGANIZATION<br />

Dr Rolf Adlung<br />

Geneva


WHO Secretariat<br />

Dr Abdel Aziz Saleh, Special Adviser (Medicine), WHO/EMRO<br />

Dr Raouf Ben Ammar, WHO Representative, Morocco<br />

Dr Belgacem Sabri, Director, Health Systems <strong>and</strong> Services<br />

Development, WHO/EMRO<br />

Dr Nick Drager, Senior Adviser, SDE, ETH, WHO/HQ<br />

Dr Jaouad Mahjour, WHO Representative, Lebanon<br />

Dr El Fatih El Samani, WHO Representative, Oman<br />

Dr Ibrahim Abdel Rahim, WHO Representative, Tunisia<br />

Dr Sameen Siddiqi, <strong>Region</strong>al Adviser, Health Policy <strong>and</strong> Planning,<br />

WHO/EMRO<br />

Dr Amr Mahgoub, <strong>Region</strong>al Adviser, Health Management Support,<br />

WHO/EMRO<br />

Dr Zafar Mirza, <strong>Region</strong>al Adviser, Essential Drugs <strong>and</strong> Biologicals,<br />

WHO/EMRO<br />

Dr Ong-arj Viputsiri, Acting <strong>Region</strong>al Adviser, <strong>Research</strong> Policy <strong>and</strong><br />

Cooperation, WHO/SEARO<br />

Dr Benjamin Ng<strong>and</strong>a, Focal Person for Trade <strong>and</strong> Health Issues,<br />

Division of Health Environments <strong>and</strong> Sustainable Development,<br />

WHO/AFRO<br />

Dr Zein El Din Idrissi, Health Economics, WHO/EMRO<br />

Mr Kevin Eisenstadt, Editor, WHO/EMRO<br />

Mrs Hanaa Ghoneim, Senior Administrative Assistant, WHO/EMRO<br />

Ms Lamia Torki, Secretary, WHO/EMRO

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!